CELEBRATING 10 YEARS OF ENTREPRENEURIAL SUCCESS · Professor Peter Clinch, UCD Vice-President for Innovation 2. NovaUCD’s success in the area of technology transfer is equally compelling:

Produced by the UCD Office of the Vice-President for Innovation

NovaUCD - Centre for New Ventures and EntrepreneursNovaUCD - Ionad d’Fhiontair Nua agus d’Fhiontraithe

NovaUCDCELEBRATING 10 YEARS OF

ENTREPRENEURIAL SUCCESS2003-2013

NovaUCD’s Impact 2003 -2013

“Great things are not done by impulse, but by a series of small things brought together.”

Vincent van Gogh (1853-90)

Creating a Dynamic Entrepreneurial Community, Professor Peter Clinch, UCD Vice-President for Innovation 2

Towards a Shared Vision for Innovation, Frank Ryan, CEO, Enterprise Ireland 4

Innovation, the Way Forward for Ireland Inc., Kevin Cooney, Managing Director Xilinx EMEA and Corporate CIO 6

Innovation at University College Dublin 8

NovaUCD, the Centre for New Ventures and Entrepreneurs 9

Making a Real Economic Impact 10

Supporting New Ventures and Entrepreneurs 12

Managing Technology Transfer 17

Case Studies Enterprising Academic Creates Jobs 20Savouring the Taste of Success 22Revolutionising the Diagnosis of Sleep-Disordered Breathing 24Using DNA to Pick a Winner 26Keeping Things Cool in Space 28

Office of the Vice-President for Innovation 30

NovaUCD Location and Directions 31Appendices From University Industry Centre to NovaUCD 32

NovaUCD Client Companies 33NovaUCD Graduate Companies 34Winners of the NovaUCD Campus Company Development Programme Award (2004-2012) 35Winners of the NovaUCD Innovation Award (2004-2012) 36Listing of Inventions Disclosed by UCD Researchers (2004-2013) 37

ContentsNovaUCD has anunparalleledinfrastructure, a rangeof comprehensivesupport programmesand a peer-supportsystem that hasnurtured anenthusiastic anddynamic community of highly talentedentrepreneurs.

page

At UCD, innovation sits alongside research and education as one ofthe three pillars of the University.

UCD is a leading research-intensive University that recognises the importance of scholarship,creativity, and innovation across all disciplines and the contribution they make to innovation throughthe creation of value from knowledge.

Innovation at UCD revolves around four themes: inspiring creative and innovative graduates, puttingknowledge to work through applied research, partnering with industry and the public sector, andgrowing and supporting new business.

Ten years ago UCD seized first-mover advantage and created a world-class, custom-built incubationfacility based around one of its historic Georgian buildings. Today, NovaUCD has an unparalleledinfrastructure, a range of comprehensive support programmes and a peer-support system that hasnurtured an enthusiastic and dynamic community of highly talented entrepreneurs.

In this publication we celebrate these 10 years of entrepreneurial success at NovaUCD. You willread how many of our companies have gone on to achieve considerable success on the world stagewith groundbreaking technologies developed from research carried out at UCD. In a series of casestudies you can also read how this research has had an impact in sectors as diverse as equineperformance, food, healthcare, ICT and space science.

NovaUCD was funded through a unique public-private partnership and was the brainchild of itsfirst Director Dr Pat Frain. His foresight was supported by our founding sponsors - AIB Bank,Arthur Cox, Deloitte, Enterprise Ireland, Ericsson, Goodbody Stockbrokers, UCD and Xilinx.

I would like to thank Kevin Cooney of Xilinx, who makes an insightful contribution to thispublication, and all the sponsor representatives who over the last 10 years have helped make theNovaUCD vision a reality.

NovaUCD’s achievements are shown, in part, by the strong results from our 10-year economicimpact survey featured in this publication. Some highlights of BiGGAR Economics’ analysis of thedata include:

• NovaUCD’s entrepreneurial and commercialisation activities currently support over1,000 jobs in the Irish economy alone and this figure is expected to grow to over 1,900jobs by 2016.

• NovaUCD client and graduate companies currently employ some 600 individuals and expect to create over 850 new jobs within the next three years.

• The combined current annual turnover of NovaUCD-supported companies is in excess of €70 million and, to date, they have raised over €90 million in equityfunding.

Over the next 10 years these outcomes will be more fully realised as NovaUCD’s early-stagecompanies further develop and fulfill their ultimate employment and earnings potential.

Creating a Dynamic Entrepreneurial Community Professor Peter Clinch, UCD Vice-President for Innovation

NovaUCD’s success in the area of technology transfer is equally compelling:

• Over the last 10 years gross commercialisation income to UCD has been in excess of €5 million.

• 30 spin-out companies have been incorporated.

• Just under 320 patent applications have been filed, almost 450 inventions have been disclosed and over 80 licensing deals have been concluded.

While we have become accomplished at spinning-out the University’s expertise, we have alsowelcomed young spin-in companies and helped them develop innovative products and servicesthrough partnerships with UCD-based researchers. An excellent example of this is surfacetechnology company Enbio (featured as one of our case studies) which relocated to NovaUCDfrom Cork and has since become a supplier to the European Space Agency.

All of this success is due in no small part to the highly skilled team at NovaUCD and, of course, tothe researchers across the campus whose expertise, hard work and commitment provide the rawmaterial without which none of this would happen.

We are also very appreciative of the continuing support of Enterprise Ireland under the TechnologyTransfer Strengthening Initiative and I am delighted that Frank Ryan, CEO of Enterprise Ireland, hasshared his thoughts on 10 years of NovaUCD with us in this publication.

Looking to the future, as NovaUCD moves into its second decade, we believe that many of themost promising commercial opportunities that lie ahead will result from the convergence ofknowledge, for example, in the fields of connected health and medical devices, where technologyand healthcare solutions combine. UCD is Ireland’s largest university and one of the largestrepositories of knowledge in Ireland. Therefore the opportunities ahead of us are immense.

The Vice-President’s team, which is based at NovaUCD, is playing an important role in broadeningthe awareness of what innovation means within a modern university and reflecting the fact that itmust embrace traditionally accepted areas of science and technology but also emerging strandssuch as social entrepreneurship, policy innovation and transfer, design, and cultural innovation. Allof this must be realised so that UCD can play its full role in economic and social development.

In recent years UCD has been expanding its global footprint with, for example, the establishmentof new campuses in China. Indeed, one day soon, we may see the development of NovaUCD hubsoutside of Ireland. We are in no doubt that an exciting future lies ahead for NovaUCD.

At the launch of the Intellectual Property Protocol, Putting Public Research to Work for Ireland, in June 2012, at NovaUCD are (l-r): Professor Peter Clinch, UCD Vice-President for Innovation;

Seán Sherlock TD, Minister for Research and Innovation; Richard Bruton TD, Minister for Jobs, Enterprise and Innovation and Dr Hugh Brady, UCD President

Enterprise Ireland has been a strong supporter of NovaUCD sinceits formation not least because both organisations share a vision tofoster innovation, encourage the creation of knowledge-intensiveenterprises and promote the commercialisation of academicresearch.

To date Enterprise Ireland, the State organisation responsible for the development and growth ofIrish enterprises in world markets, has provided funding of approximately €7 million to UCD toassist with the original development of the NovaUCD facility itself and to support UCD’stechnology transfer office as part of the national Technology Transfer Strengthening Initiative acrossthird level institutes.

“The fact that Enterprise Ireland has put this level of funding into UCD is a huge vote of confidencein the team at NovaUCD and in what they have achieved to date and the potential for what theycan achieve going forward,” says Enterprise Ireland CEO, Frank Ryan.

“As an organisation we are seeking to drive the commercialisation of research and in particularthe creation of high potential start-ups from that research in order to create quality jobopportunities. We are of the view that Ireland can be the ‘comeback economy’ of Europe but to

do that the country will have to increase exports of products and services. Publicly funded researchwithin third level institutions has to play a very active role in achieving this. The types of productsand services in demand from Ireland today are sophisticated. It is quite likely that they willincreasingly come from technologies being developed in universities and from spin-out companiessuch as Equinome which is based at NovaUCD.”

Enterprise Ireland has now funded incubation facilities at virtually every university and institute oftechnology in the State. These centres are home to roughly 350 young companies employing some1,500 people.

“We are pleased with the progress to date in these centres but Ireland needs stronger results andwe believe that the very professional team at NovaUCD has the experience to do the job,” Ryansays. “We also see a huge benefit in NovaUCD having access to the research competencies withinUCD in general. That’s a huge foundation for future growth.”

Ryan believes that as a developed economy, Ireland must look for growth and employmentopportunities in different places to developing economies. Based on the experience of developedeconomies such as the US and Japan, the most likely sources of these opportunities includeentrepreneurs and start-up businesses.

Towards a Shared Vision for Innovation An interview with Frank Ryan, CEO, Enterprise Ireland

“We are very strong in sectors such as software, digital media and medical devices and there areclear opportunities in the market for innovative products and services within these sectors,” Ryansays. “Centres such as NovaUCD have a big role to play and are now a fundamental part of ourecosystem for the generation of new technology companies.

“Our recent evaluation of how centres such as NovaUCD are performing shows that 90% ofrespondent companies felt that being located in a campus incubator contributed positively to thegrowth of the company,” Ryan adds. “In addition 45% viewed the interaction they had with othertenants as highly valuable to the development of their companies while 26% had actually donebusiness or formed business partnerships with companies that were in their incubation network.”

Ryan says that the Technology Transfer Strengthening Initiative was designed to increase the numberof technologies that would be identified and successfully licensed to industry. This has paid dividendsat UCD where gross commercialisation income over the last 10 years has now exceeded €5million.

“There has been an almost four-fold increase in the number of spin-out companies from technologytransfer offices since the initiative was launched six years ago,” Ryan says. “Ireland currently rankswell above the EU averages in the number of licenses and spin-out companies it generates. Forexample, we rank third in Europe in terms of the number of start-ups and fourth for the numberof technologies transferred to industry. NovaUCD is a key component of Ireland’s technologytransfer system and exemplifies what we excel at here in Ireland.”

“I would see the number of spin-in companies also growing. Last year Enterprise Ireland helped12 overseas entrepreneurs establish high potential start-ups in Ireland and will do the same againthis year. In doing so we compete against the likes of London, Berlin, and Silicon Valley for talent.That whole world of mobile entrepreneurship is increasing considerably and we intend to be partof it,” Ryan says.

“The results of the NovaUCD economic impact survey are very positive and we think there is agreat future for Ireland through the Technology Transfer Strengthening Initiative,” he continues.“Indeed Enterprise Ireland is establishing a centralised technology transfer office and the level ofinteraction with NovaUCD is going to deepen. We expect big things from NovaUCD as they havea proven capability to commercialise research and to assist with the development of very successfulspin-out companies such as BiancaMed and ChangingWorlds.”

“From Enterprise Ireland’s point of view the ultimate objective is jobs and exports and beinginvolved in leading-edge applied science that can ultimately be commercialised is key. There is arelentless drive towards a knowledge-based society and an ecosystem that includes NovaUCD isvery attractive and advantageous for the country,” Ryan concludes.

NovaUCD is a key component ofIreland’s technology transfer systemand exemplifies what we excel athere in Ireland.

Seminar at NovaUCD

Xilinx is the world’s largest manufacturer of high-poweredmicrochips, commanding half the world market for these products.It has revenues in excess of US$2 billion and employs 3,000people worldwide.

Over the last 20 years Xilinx has developed close connections with Ireland as an active memberof the foreign direct investment community, and as one of the founding sponsors of NovaUCD.

Xilinx designs and develops the microchips used across a broad spectrum of industrial, scientificand medical device applications. The company operates in a fast moving R&D world whereinnovation is critical and it is accustomed to bringing new products to market within tight timeframes. Xilinx is at the leading edge of its industry and the fruits of its extensive research haveresulted in the registration of over 2,500 patents since its formation in 1984.

Underpinned by a strong innovation culture, Xilinx recognised the significance of NovaUCD’s visionand mission from the outset and was keen to support it. “Xilinx believed that backing NovaUCDwas worth doing, whether or not we ever derived any direct benefit from our involvement. It wasabout contributing to a bigger picture, not about getting anything specific for ourselves,” says thecompany’s most senior executive in Europe, Irish-born Kevin Cooney, who is Managing Directorof its Dublin-based European headquarters, corporate Vice-President and Chief Information Officer.

“Putting money into the establishment of NovaUCD was a business decision, not least because itwas a highly innovative project that struck a chord with us,” he adds. “Through NovaUCD wecould see the University taking a strategic role that complements its teaching and research roles.It enables the academic and student communities to use their knowledge base to develop somethingbeyond the confines of the University, something with the potential to create employmentopportunities for graduates and revenue for the country through spin-out companies. The futureand potential growth of Ireland Inc. is linked to our capacity to innovate. If we do not innovate wewill fail and centres such as NovaUCD are the natural home of bright individuals with high potentialinnovations.”

While Cooney has spent a large part of his career working for multinational companies, he is in nodoubt about the need to foster and support the development of indigenous businesses andexpertise. “We need places like NovaUCD where people can bring their ideas and develop theminto solutions that in turn build companies with export potential,” he says. “As a company wewanted to play our part in this and over the last 10 years we have seen the growth of a high calibreskills base at NovaUCD that supports entrepreneurs not only with technical back-up but also withthe business acumen needed to drive their ideas to commercial success.”

Innovation - The Way Forward for Ireland Inc. An interview with Kevin Cooney, Managing Director Xilinx EMEA and Corporate CIO

Cooney spends a great deal of his time in the US and is no stranger to the highly professionalincubation hubs created by US universities such as Stanford. He says NovaUCD compares veryfavourably. “It’s not just about having ideas and smart people; an idea is only as good as itsrealisation,” he says. “It’s also about developing a fostering environment and creating an atmospherethat gives people the best possible chance of success. Entrepreneurs often start out with one ideaand discover, as that idea evolves, that they need to go in a different direction. They need space todo this. The lay-out of the NovaUCD building is very conducive to good interaction between thecompanies based there and this mutual support and information sharing is very important at thestart-up stage. So, too, are the links and contacts that NovaUCD and UCD have made by interactingwith industry.

“We have spoken with a number of NovaUCD companies over the years that were working onideas that were relevant for us. When I look at NovaUCD I see an organisation that has spent adecade building very solid foundations that have delivered excellent results,” Cooney adds.

Xilinx has recently increased its own employment in Ireland by 60 to 340 people and for Cooneytwo key statistics that jumped out of NovaUCD’s economic impact survey were the approximately600 jobs that have been created by NovaUCD companies so far and the estimated 850 additionaljobs that will be created by 2016.

“It takes time to create an embedded infrastructure to support an entrepreneurial culture. I believethat NovaUCD has successfully done this and is now moving to the next level under its currentleadership,” Cooney says. “NovaUCD is a very enabling environment. If you look at the number ofpatents filed, for example, it is hugely encouraging as it reflects the level of innovation taking placeat UCD and the potential for great business opportunities.”

“UCD has shown both vision in establishing NovaUCD and a very strong commitment to makingit work. The centre is going to go from strength to strength and I think it is going be even moresuccessful in its next decade. Ultimately, the more successful NovaUCD is, the better it will be forIreland Inc.”

Putting money into the establishment ofNovaUCD was a business decision, notleast because it was a highly innovativeproject that struck a chord with us.

NovaUCD courtyard

Innovation is a key element of University College Dublin’s core mission and sits as an equal pillarof the University alongside education and research. UCD, Ireland’s global University, justly pridesitself on being a world-class, research-intensive University where excellence in education iscombined with a commitment to research, creativity and innovation.

UCD’s commitment to innovation recognises the importance of actively participating, contributingand collaborating to exploit leading-edge research and development outputs.

Professor Peter Clinch is UCD’s Vice-President for Innovation and he leads the Office of the Vice-President for Innovation at the University.

The mission of the Office of the Vice-President for Innovation is to enhance the value and qualityof UCD’s innovation activities in order to achieve the maximum impact for the University, itspartners, and for social and economic life in Ireland in the wider world.

To advance this mission, the Office of the Vice-President for Innovation supports system-wideinnovation activities across the University, including technological, policy, social and culturalinnovation, through four innovation themes:

Inspiring Creative GraduatesUCD provides leading-edge programmes to ensure that UCD’s graduates are highly-skilled,innovative and entrepreneurial and compete effectively for international employment.

Putting Knowledge to WorkThe Office of the Vice-President for Innovation promotes initiatives that provide integratedsolutions to global problems through problem-driven research at the University.

Through its technology transfer team, the Office of the Vice-President for Innovation engages withUCD’s research community to commercialise the outputs of their research programmes.

Partnering with IndustryThe Office of the Vice-President for Innovation is a core interface between the University and theneeds of industry and it promotes the creation and development of business partnerships includingthe licensing of UCD technology.

The Office of the Vice-President for Innovation also develops, advises and manages programmesand activities that support and enhance a vibrant environment for collaboration with local, nationaland global companies.

Growing and Supporting New BusinessThe Office of the Vice-President for Innovation manages NovaUCD, the University’s Centre forNew Ventures and Entrepreneurs. At NovaUCD, in state-of-the-art facilities, new high-tech andknowledge-intensive companies are nurtured and supported to enable them to grow, develop andcreate jobs.

Innovation atUniversity College Dublin

NovaUCD, located in a magnificent mid-18th-century house, formerly known as Merville House,has been the hub for new ventures and entrepreneurs at University College Dublin since 2003.

NovaUCD is a purpose-built, state-of-the-art incubation facility for high-tech and knowledge-intensive start-up companies. At NovaUCD a comprehensive business support programme forclient companies is also provided. This programme comprises advice, seminars and workshops aswell as facilitated access to the NovaUCD network of University researchers, business leaders andinvestors.

At NovaUCD a highly networked community of entrepreneurs provides an environment for thepromoters of new ventures to share their experiences to assist other start-ups to develop andgrow. This innovative and entrepreneurial community, along with the wider NovaUCD network,creates an invaluable support for client companies.

The concept for the NovaUCD facility, designed by Brian Kavanagh of Kavanagh Tuite Architects,was to restore the original house as the centrepiece of a complex of subsidiary buildings thatsurround it. The buildings are bright, airy and open with high-quality shared and circulation spacesthat encourage the formal and informal interactions necessary for the development of a communityof entrepreneurs.

The conversion to a modern centre for new ventures and entrepreneurs was funded by a uniquepublic-private partnership which was established by Dr Pat Frain, then Director of NovaUCD.

Six private sector sponsors, AIB Bank, Arthur Cox, Deloitte, Ericsson, Goodbody Stockbrokers,and Xilinx, contributed 75% of the €10 million raised to develop the first two phases of theNovaUCD complex.

These sponsors were chosen to bring an appropriate mix of expertise and experience to thesupport programmes offered at NovaUCD. The balance of funds for the first two phases wascontributed by Enterprise Ireland and the University.

Additional funding of €1.3 million was provided by Enterprise Ireland and UCD for bio-incubationfacilities and equipment to accommodate biotechnology start-up companies.

NovaUCD was officially opened by An Tánaiste and Minister for Enterprise, Trade and Employment,Mary Harney TD, on 13th October 2003.

Appendix 1 contains a brief overview of UCD’s support for entrepreneurship prior to theestablishment of NovaUCD.

NovaUCD, the Centre for New Ventures and Entrepreneurs

At the official opening of NovaUCD in 2003 are (l-r): John Kelly, AIB Bank; Feargal Ó’Móráin, EnterpriseIreland; Dr Art Cosgrove, UCD President; Mark O’Donovan, Goodbody Stockbrokers; An Tánaiste,Mary Harney TD; Pádraig Ó’Ríordáin, Arthur Cox; Ian Cahill, Ericsson; Paul McCambridge, Xilinx; Pat Kenny, Deloitte and Dr Pat Frain, Director, NovaUCD 9

Making a Real Economic Impact

Since 2003, UCD has provided business development support to 242 companies and early-stageprojects through the incubation services and supports provided at NovaUCD and through theNovaUCD Campus Company Development Programme.

In the last 10 years 126 companies have been direct clients of NovaUCD and availed of desk space,bio-incubation units or business unit facilities within the on-campus centre.

These supported companies, which currently employ 599 staff, of whom 489 are in Ireland, haveraised €91 million in equity funding to date, and have a current annual turnover of €71.2 million.Furthermore, these same companies expect to create 851 new jobs by 2016, with 630 of them inIreland.

Today, NovaUCD-supported companies contribute €34.5 million a year in Gross Value Added (GVA)to the Irish economy and a further €7.7 million GVA to the international economy. Between themthese companies currently support 1,252 jobs, directly and indirectly, of which 1,022 are based inIreland and 230 internationally.

Since 2003 the University has earned €5.2 million in commercialisation income. This includes €3million from the sale of shareholdings in spin-out companies and €2.2 million in royalty-relatedincome, of which 12% has come from Irish-owned companies, 54% from multinational companieswith a base in Ireland and 34% from multinationals with no Irish presence.

As a direct result of entering into licensing agreements with UCD, businesses have been able toincrease their annual turnover in Ireland by an average €3.6 million and international turnover by€5.8 million.

The Office of the Vice-President for Innovation commissioned BiGGAR Economicsto carry out an economic impact analysis of NovaUCD’s entrepreneurial and com-mercialisation activities over a 10-year period from 2003 to 2013.

The study findings were based on two main information sources. Current turnoverand current and future employment figures for companies supported byNovaUCD since 2003 were collected, amongst other data, via a survey carriedout in summer 2013 with a 70% response rate. Data on commercialisation incomeand other technology transfer related metrics for the period was provided directlyby the Office of the Vice-President for Innovation.

Analysis of the collected data by BiGGAR Economics uses Gross Value Added(GVA) which is generally regarded as the best measure of the total wealth creationin a given area. It is the difference between the value of goods and servicesproduced (outputs) and the cost of raw materials and other inputs.

1,341NovaUCD activities support a total of 1,341jobs currently worldwide, 1,056 in Ireland

Intellectual property developed at UCD currently generates an additional €2.1 million GVA forthe Irish economy and an additional €3.4 million GVA for the international economy and supportsa total of 89 additional jobs each year.

The scale of NovaUCD's contribution to Ireland's economy looks set to increase significantly inyears to come.

BiGGAR Economics estimate that, by 2016, existing supported companies will be generating €64million GVA for the Irish economy each year and directly and indirectly supporting 1,900 jobs inIreland, as well as contributing €18.2 million GVA and supporting 538 jobs in the internationaleconomy each year.

By 2016 total entrepreneurial and commercialisation activities at NovaUCD, assuming that theincome generated by intellectual property remains in line with the trend of the past 10 years, willbe generating €87.7 million GVA a year and supporting directly and indirectly some 2,527 jobs inall. Some €66.1 million of this GVA and 1,934 of these jobs will be within Ireland.

NovaUCD – Key Economic Impact Data (2003-2013)

Companies supported• 242: Companies and early-stage projects supported • 126: Companies incubated at NovaUCD • 30: UCD spin-out companies incorporated

Commercialisation activities • €6.3 million: Value of R&D collaboration with UCD by NovaUCD-supported companies • €5.2 million: UCD’s commercialisation income• 445: Inventions disclosed • 318: Patents filed• 81: Licence agreements concluded

Equity and turnover• €91 million: Equity funding raised • €71.2 million: Current annual turnover of NovaUCD-supported companies

Current employment impact• 1,056: jobs (direct & indirect) currently supported by NovaUCD’s activities in Ireland• 285: jobs (direct & indirect) currently supported by NovaUCD’s activities outside of Ireland

Current economic value• €36.6 million: NovaUCD’s total annual GVA contribution to the Irish economy• €11.1 million: NovaUCD’s total annual GVA contribution to the international economy

Expected employment impact by 2016• 1,934: jobs (direct & indirect) supported by NovaUCD’s activities in Ireland• 593: jobs (direct & indirect) supported by NovaUCD’s activities outside of Ireland

Expected economic value by 2016• €66.1 million: NovaUCD’s total annual GVA contribution to the Irish economy• €21.6 million: NovaUCD’s total annual GVA contribution to the international economy

Donal Ryan, Manging Director and Dr Emmeline Hill, Co-founder, Equinome

€47.7 millionNovaUCD activities support an annual contribution of €47.7 million(gross value added) to the worldwide economy, €36.6 million in Ireland

University College Dublin has a proven track record in supporting entrepreneurs and newventures on campus at NovaUCD, from the early feasibility stage, through to businessdevelopment, growth and investment.

Office FacilitiesThe buildings at NovaUCD, which cover 4,500 sq.m., are bright, airy and open with high-qualityshared and circulation spaces that encourage the informal and formal interactions necessaryfor the development of a community of entrepreneurs.

At NovaUCD a wide range of flexible occupancy options (desk space, business units and bio-incubation) are provided to entrepreneurs to enable them to move as their businesses grow. The office facilities consist of 14 desk spaces, 45 business units (ranging from 12 sq.m. to 64sq.m.) and 10 bio-incubation units (ranging from 17 sq.m. to 64 sq.m.).

The bio-incubation units are equipped with power and water supply, sinks, fume hoods andbenching, as well as voice and data points. Shared facilities available include fridge freezers, de-ionised water, ice machines, dishwashers etc.

Additional Facilities and ServicesAt NovaUCD, which has 24/7 access, additional facilities and services include; reception services,a permanent boardroom, seminar and meeting rooms, a dedicated video conferencing room,wireless network, a dedicated server room and a café with external decking.

Supporting New Venturesand Entrepreneurs 2,527

NovaUCD activities will be supporting a total of2,527 jobs worldwide by 2016, 1,934 in Ireland

Facilities at NovaUCD12

Support Programme for New VenturesA comprehensive business support programme is offered to clientcompanies. This comprises advice, clinics, seminars and workshops aswell as facilitated access to the NovaUCD network of world-class UCDresearchers, business leaders, NovaUCD sponsors and investors.

Workshops and seminarsAt NovaUCD a series of workshops and seminars are provided onaverage three times per month on topics based upon clientrequirements. The workshops cover issues which affect knowledgeintensive start-up companies such as: raising investment, businessdevelopment and sales, finance and tax, product positioning andintellectual property. The workshops generate group discussion andinteraction around key issues and assist clients to establish newnetworks as part of the community of entrepreneurs at NovaUCD.

In addition, a specialist investment series frequently takes place atNovaUCD which brings in investors to discuss their funds and providesthe opportunity for clients to interact with investors informally througha one-to-one meeting.

Dr Hermann Hauser, serial tech entrepreneur and venture capitalist,speaking at a NovaUCD seminar

€87.7 millionNovaUCD activities will be supporting an annualcontribution of €87.7 million (gross value added) to theworldwide economy by 2016, €66.1 million in Ireland

Brendan Clavin and Brian Farrell, Co-founders, Tethras

Tethras, based at NovaUCD, provides a localization andtranslation service for mobile apps

€71.2 millionNovaUCD-supported companieshave a current annual turnoverof €71.2 million

NovaUCD Client CompaniesOver 45 innovative new ventures are current clients at NovaUCD. Many of these are spin-out companies that are commercialisingresearch specifically undertaken at UCD. The remaining are spin-in companies that have located at NovaUCD in order to interactmore closely with the University. See Appendix 2.

In addition over 50 companies have graduated from NovaUCD and moved on to new premises. It is an important element ofNovaUCD’s strategy to refresh continuously our community of entrepreneurs and to have the capacity at all times to take on newprojects. See Appendix 3.

Current clients include:

126126 companies have beenincubated at NovaUCD during the last 10 years

NovaUCD Campus Company Development ProgrammeThe NovaUCD Campus Company Development Programme (CCDP), which ran annually from1996-2012, was the main support programme run at NovaUCD for UCD academic and researchentrepreneurs who were establishing UCD spin-out companies.

The aim of the CCDP was to assist such entrepreneurs in the establishment and developmentof knowledge-intensive enterprises to commercialise the output of their research and otherinnovative ideas.

The programme assisted participants to define and develop their innovative ideas and to preparea detailed business plan.

Each year the programme culminated in an awards evening during which the promoters of eachproject delivered an ‘elevator pitch’ to an invited audience. The business plans of threeshortlisted projects were then presented in detail before the panel decided on the overall winnerwho was presented with the annual NovaUCD CCDP Award.

The winners of this award for each year since 2004 are provided in Appendix 4.

VentureLaunch AcceleratorThe NovaUCD Campus Company Development Programme has been further developed andenhanced and, from September 2013, it will be called the UCD VentureLaunch AcceleratorProgramme.

VentureLaunch, which uses the Business Model Canvas approach, is UCD’s new acceleratorprogramme, held at NovaUCD, to support the creation and launch of sustainable and profitablenew ventures based on UCD intellectual property.

The objective of the programme, run by staff of the Office of the Vice-President for Innovation,is to equip UCD researchers with the knowledge, skills and understanding that will be requiredto work as part of a team leading a new commercial venture. On completion of the programme,the expectation is that participating new venture projects will have developed a commerciallyviable business plan.

The annual programme will end with an annual showcase event during which the overall winnerof the programme will be announced.

UCD Commercialisation BootcampIn 2013 a new UCD Commercialisation Bootcamp was delivered for the first time. TheBootcamp took place over a five week period at NovaUCD. The overall aim of the Bootcamp,which will run twice a year, is to strengthen the pipeline of commercial opportunities arisingfrom UCD research programmes.

The Bootcamp’s objective is to equip academic researchers, staff and postgraduate researchstudents with the knowledge, skills and understanding of the commercialisation process.

On completion of the Bootcamp, participants will have developed a solid awareness of what ittakes to build a commercialisation plan around their research outputs.

It is envisaged that researchers who complete this new Bootcamp, and whose commercialisationstrategy includes the establishment of a spin-out company, may progress to participate on theVentureLaunch Accelerator Programme.

Dr Peter Richardson, a postdoctoral researcher in UCD’s School of Electrical, Electronic andCommunications Engineering, a participant on the first UCD Commericalisation Bootcamp

3030 UCD spin-out companies have been incorporated over the last 10 years

The primary function of UCD’s technology transfer team, which is based at NovaUCD, isbuilt around the key activities of:

(i) identifying intellectual property (IP) arising from UCD research programmes

(ii) protecting this IP as appropriate

(iii) commercialising this IP whether through licensing to a commercial partner or through the creation of a spin-out company.

UCD’s technology transfer operations are partially supported with funding provided byEnterprise Ireland under the Technology Transfer Strengthening Initiative.

Identifying, Protecting and Commercialising Intellectual PropertyUCD has a structured approach to ensure that intellectual property is identified andappropriately protected. Members of the technology transfer team regularly meet with UCDresearchers to provide advice on commercial aspects of research proposals and contracts,to monitor the progress of research projects and provide appropriate assistance to theresearchers at the different stages of their research projects. They also remind researchersof the University’s contractual obligations to funding agencies and companies. In addition theyalso implement the University’s policy on intellectual property.

The UCD technology transfer team is primarily responsible for ensuring that the intellectualproperty terms on ownership and access rights reflect the objectives of the project, do notconflict with any other agreements into which UCD has entered, comply with State Aid Rules,the requirements of the Funding Agency Guidelines and National Codes of Practice, andimportantly preserve wherever possible the researcher’s right to publish and use theintellectual property in future research projects.

Managing Technology Transfer

€5.2 millionUCD’s commercialisation income over the last10 years is €5.2 million

NovaUCD reception area

445445 inventions have been disclosed byUCD researchers during the last 10 years

Links with Industry & Commercial OpportunitiesBridging the gap between academic research and industry, and building relationships with industry, are keyelements of UCD’s commercialisation strategy. The University, through the Office of the Vice-Presidentfor Innovation, has a growing portfolio of licence deals. These will benefit the companies licensing thetechnology by making them more competitive, helping them to create new products, achieve scale andgenerate employment. Hopefully, with time, this will yield financial returns to the University and theinventors.

NovaUCD Innovation AwardThe NovaUCD Innovation Award was established in 2004 and is presented annually to an individual,company, organisation or group in recognition of excellence in innovation or of success achieved in thecommercialisation of UCD research or other intellectual activity.

Recipients of this award since 2004 are listed in Appendix 5.

Note: A listing of the UCD researchers who have disclosed inventions to the UCD technology transferteam since 2004 is provided in Appendix 6.

318UCD has filed 318 patents during the last 10 years

81UCD has concluded 81 licences withnational and international businessesduring the last 10 years

UCD Commercialisation Process

NovaUCD courtyard at night

€91 millionNovaUCD-supported companies have to dateraised €91 million in equity funding

Case StudyEnterprising Academic Creates Jobs

Some people find it hard to manage one job.Professor Barry Smyth juggles three – teacher,researcher and entrepreneur.

Professor Barry Smyth

Some people find it hard to manage one job. Professor Barry Smyth juggles three - teacher,researcher and entrepreneur. Smyth holds the Digital Chair of Computer Science at UCD andhe loves the lecturing and research aspects of this role. However, he also has a knack for spottingideas with strong commercial potential. Smyth has been the driving force behind two UCDspin-out companies, ChangingWorlds founded in 1999 and HeyStaks established in 2008.

Smyth rarely stands still. UCD has filed more patents (eight) for inventions resulting from Smyth’sresearch than any other researcher at UCD in the last 10 years. He has published in excess of400 research papers, has led research projects worth in excess of €57 million and is the Directorof the Science Foundation Ireland-funded CLARITY: Centre for Sensor Web Technologies andthe recently established INSIGHT Centre. Smyth is also an experienced industry collaboratorhaving partnered with companies such as Vodafone, Givaudan, Amdocs and SkillPages.

Clever ideas are central to what makes Smyth the researcher tick. But Smyth the entrepreneuris careful not to let his enthusiasm for an idea cloud his commercial judgment. “I think I have adecent instinct for these things but I’m a firm believer in filtering ideas, not the good from thebad, but the ones that are commercially relevant from the ones that are not,” he says.

“Since NovaUCD was established it has always been my first port of call to bounce an idea orpursue IP protection. There is a huge amount of complexity around getting companies off theground. Anything that helps make it easier is much appreciated. We still do the heavy lifting butat NovaUCD, training, guidance and great facilities such as easy access to office space oncampus are provided. Life would be much more difficult if I was trying to commute betweenCollege and an office in town for example.”

With Smyth’s involvement, ChangingWorlds became a leading global provider of mobile contentdiscovery systems employing some 150 people. Its advanced research centre was based atNovaUCD until 2008 when the company was acquired by Amdocs, a global leader in unifiedcommunications and network services solutions. A significant number of Smyth’s former seniorresearch students found employment with ChangingWorlds. This was a good outcome for theUCD graduates, but also for the company as it was heavily populated with experienced PhDsas a result.

Smyth loves building solutions and says the best way of seeing them come to fruition is throughdeveloping products that people use. “ChangingWorlds is a mature example of this process asthe technology ultimately found its way into the hands of millions of people,” he says. “It predatesApp stores so anyone using the mobile Internet on a smart phone a few years ago was probablyusing ChangingWorlds software.”

“By comparison HeyStaks is at an early-stage in its development. We have just finished a productdevelopment cycle and currently employ just under 10 people. In about a year’s time we will belooking to recruit between 30 and 40 people as we move to the next phase of ourdevelopment.”

Smyth says he learnt a lot from participating in the NovaUCD Campus Company DevelopmentProgramme. “I did it in 1999 and have sent numerous students on it since. It’s a great way ofbroadening the mindset of someone doing a PhD whose head is deep in their research. It makesthem think more commercially about what they’re doing,” he says.

“For me setting up ChangingWorlds was about getting the technology into the hands of realpeople and seeing how it worked. As a researcher you develop ideas and then try to evaluatethem. But lab conditions are often unsatisfactory because they are small scale and an artificialevaluation environment - especially for the type of software we were building. The secondreason for spinning-out is to create a business that brings jobs. I have a view of research thatincludes patenting, protection and commercialisation. As funded academics I think we have anobligation to try to develop something beyond the research bench where that’s possible.”

Smyth says that as a busy academic, the support and services at NovaUCD have played a bigpart in helping him express his entrepreneurial spirit.

“This may sound like a strange thing to say, but when you’re involved in really exciting researchas I am, there is huge competition for your head. There are often more interesting things I couldbe working on instead of company development stuff. If there hadn’t been support providedthrough NovaUCD it would have been all too easy to have focused on something else andmaybe let the projects fall by the wayside.”

“Since NovaUCD was established it has always been my first port of call to bounce an idea or pursue IP protection.”

Case StudySavouring the Taste of Success

Researchers at the UCD Institute of Foodand Health have spent the last two yearsdeveloping a new health food technologythat delivers every snack food lover’s dream- healthy, guilt-free nibbles.

Professor Dolores O’Riordan

Researchers at the UCD Institute of Food and Health have spent the last two years developinga new health food technology that delivers every snack food lover’s dream - healthy, guilt-freenibbles.

The research team is led by Professor Dolores O’Riordan, Director of the Institute and a leadingresearcher in the UCD School of Agriculture and Food Science. Under her guidance the teamhas developed and patented ground-breaking technology with the potential to produce a savourysnack that is high in protein and fibre but low in fat and salt.

Professor O’Riordan has a long track record of successful engagements with industry and, inconjunction with UCD’s technology transfer team based at NovaUCD, brought the technologyto the point where it was ready for marriage with a commercial partner. Through the effortsof UCD and Enterprise Ireland, the technology has now been licensed to Largo Foods, themakers of one of the nation’s favourite snack foods - Tayto crisps.

Largo Foods is a major producer of savoury snacks in Ireland. Apart from Tayto, the companyalso manufactures King, Perri and Hunky Dorys, and has a 50% share of the Irish snack foodsmarket.

The significance of the technology developed by the UCD research team was immediatelyrecognised by Largo’s Operations Director, John Donnelly. “The technology represents a verydifferent take on how to make a snack product and is quite ‘out there’ in terms of innovativethinking and breaking new ground,” he says. “In its raw state it was some distance away frombeing usable in a full scale manufacturing setting to create a commercially viable product.However, we felt it was worth taking the opportunity of developing the technology further asthe potential reward is huge.”

“I come from a food science background so product and process are two of my areas of interestand I was very interested by what UCD had come up with,” adds Donnelly whose responsibilitiesat Largo cover manufacturing, quality and new product development.

The UCD team presented the technology to Largo two years ago and Professor O’Riordansays a strong relationship has developed between the two organisations since. “We visited Largoto learn how its business worked and to understand its ethos and we found a company thatwas progressive, open to new ideas and willing to take a risk. Largo is very entrepreneurial andnot at all wedded to convention,” O’Riordan says.

Once the licensing agreement was put in place work began in UCD on scaling up the technologywhile Largo began looking at the potential from the consumer perspective, identifying what styleof product was needed and where it might be positioned in the market.

“The product is quite different to anything else that’s out there. The texture and flavour arenot like your typical dense high fibre snack,” O’Riordan explains. “What we’ve achieved isinnovative on two levels. The combination of ingredients we have put together is unusual butso too is the manufacturing process. Indeed the really challenging part for the researchers hasbeen to create and scale the manufacturing technology in a way that takes account of key factorsin a commercial environment such as energy costs.”

The process of patenting the technology and finding a suitable company to buy it was undertakenby UCD’s technology transfer team which is based at NovaUCD.

“The UCD technology transfer team was a fantastic support throughout the whole process,”Professor O’Riordan says. “They did all of the background work and checks from the patentpoint of view and advised on the best route to take to protect the IP involved. They subsequentlyliaised with Largo Foods and drew up the terms of the agreement with them. More generallythey play an important role in training and advising researchers in the area of IP as it’s not a skillscientists would normally have.”

While Largo Foods has its own research and development facilities, John Donnelly says that itsR&D is more directly related to its day-to-day business and that resources committed toresearch are generally linked with specific commercial objectives.

“What UCD is doing for want of a better word is more ‘academic’ research in that they arenot only pushing but reinventing the boundaries and this is not something one would tend todo in a company setting,” he says. “By working with them we have gained access to that leading-edge research and to what may ultimately be a snack product with worldwide sales potential.”

“The UCD technology transfer team was a fantastic support throughout the whole process.”

Case StudyRevolutionising the Diagnosis of Sleep-Disordered Breathing

Over 60 million people in Europe and theUS alone are affected by sleep-disorderedbreathing.

Dr Conor Hanley

Sleep-disordered breathing is surprisingly common and a major contributor to health problemssuch as high blood pressure and congestive heart failure. Sound sleepers take their undisturbedrest for granted. For those who suffer from sleep-disordered breathing, there is no such thingas a good night’s sleep. Over 60 million people in Europe and the US alone are affected by thiscondition.

In 2003, the UCD spin-out company, BiancaMed, launched a pioneering product that radicallychanged how sleep disordered-breathing is diagnosed. At the heart of the company’s proprietarytechnology was a highly sensitive, radio frequency motion sensor that detected respiration andmovement without being connected to the body.

It uses sophisticated biometric software to convert motion data into a measurement of sleepand made it possible to monitor those with sleep problems at home in their natural sleepingenvironment. Prior to this, diagnosis was expensive, complicated and typically involved a patientbeing wired up to monitors in a sleep laboratory.

BiancaMed was a spin-out from research undertaken in UCD’s School of Electrical, Electronicand Communications Engineering by Professor Conor Heneghan and Dr Philip de Chazal. Thecompany’s third co-founder was Dr Conor Hanley who is widely experienced in technologycommercialisation.

BiancaMed was set up at NovaUCD in 2003 and Dr Conor Hanley says the experience of beingbased there was extremely positive. “The actual physical environment is very nice as there’s anarchitectural mixture of old and new. There’s a coffee shop at the heart of the building and thecost of a coffee was kept deliberately minimal to incentivise entrepreneurs to congregate, mingleand share ideas,” he says.

“Developing a start-up can actually be quite a lonely path and the emotional support of havingpeople around you in a similar situation was very valuable. This idea of an open area is somethingwe’ve replicated in our new offices at NexusUCD. So too is having labs close to our desks aswe did at NovaUCD. We have tried to capture some of the essence of NovaUCD by creatinga working environment that is conducive to collaboration.”

Hanley says the fledgling company also benefited from NovaUCD’s programme of guestspeakers, visits from service providers and the availability of the NovaUCD Campus CompanyDevelopment Programme. “They covered all the bases from formal business training toproviding access to experts and mentors and interaction with other companies going throughthe same process. This helped accelerate the learning process,” Hanley says.

“We have evolved quite significantly since we were set-up and the supports and servicesprovided at NovaUCD certainly made it easy to grow,” he adds. “For example, the building isdesigned in such a way that the space is flexible so you can have more room if you need it.”

One of BiancaMed’s early investors was the US-based medical devices company, ResMed, aglobal leader in the development of products for the diagnosis, treatment and management ofrespiratory disorders, particularly sleep-disordered breathing. In 2011 it acquired the company,which has since been renamed as ResMed Sensor Technologies.

“ResMed is committed to advancing innovative technology in sleep and respiratory medicineand BiancaMed was a strategic acquisition that has allowed it to expand its diagnostic range andpatient reach,” says Hanley who is now Senior Vice-President, ResMed Ventures & Initiatives.

“We had global ambitions from the start and set out with the vision of moving monitoring fromthe hospital to the home. Looking to the future there is going to be much greater connectivitybetween the home and the hospital and remote monitoring will play an increasing role in this.ResMed’s vision is helping change people’s lives one breath at a time so culturally they werequite aligned with us and it was a good fit.”

Following the acquisition, the company graduated from NovaUCD to NexusUCD, the IndustryPartnership Centre, located adjacent to the main University campus at Belfield. ResMed SensorTechnologies employs over 30 people at its new base and plans to expand its facility atNexusUCD with the creation of up to 50 new jobs over the next three years.

“Ireland has quite a few things to offer companies like ResMed such as the technology andexpertise we’ve built up here around medical devices,” Hanley says. “Secondly, there’s a lot offoreign direct investment around IT and thirdly there’s quite good industry-academiccollaboration. Other positives of being located in a small country include being able to networkquite well, test business models and interact easily with people.”

“Developing a start-up can actually be quite a lonely path and the emotional support of having people around you in a similar situation was very valuable.”

Case StudyUsing DNA to Pick a Winner

It is the question that has perplexedrace goers for generations. What makesone horse run faster than another?

Dr Emmeline Hill

It is the question that has perplexed race goers for generations. What makes one horse runfaster then another?

According to Dr Emmeline Hill, a leading horse genomics researcher and lecturer in the UCDSchool of Agriculture and Food Science, the answer lies in the genes. In 2009 her NovaUCD-headquartered company, Equinome, launched a pioneering test to prove it.

Hill’s research into the so-called “speed gene” began in 2004 when she received funding fromScience Foundation Ireland to look at the genetic influences on racing performance inThoroughbred horses. Hill comes from a family steeped in the horseracing tradition and it washer unique combination of scientific and industry knowledge that led to the development ofthe Equinome Speed Gene Test.

Built around scientific excellence, Equinome’s proprietary technology can predict the best racedistance (short, middle or long) for an individual horse. This has the potential to transform howthose in the multi-billion global bloodstock industry make key decisions. For example, racehorseowners and trainers can use the information for purchasing and training and to identify themost appropriate races for their horses. Breeders, stallion managers and bloodstock agentscan use the test to make more precise selection and breeding decisions.

Hill says the support and backing of NovaUCD and her partnership with horse trainer, JimBolger, were key elements in the successful launch of Equinome. “I didn’t start out with theexpectation of building a successful global business but in fact that is what has been achieved.We have customers in 14 countries in all the major bloodstock regions in the world,” she says.

While Equinome was still taking shape, Hill joined the NovaUCD Campus CompanyDevelopment Programme, a nine-month, part-time enterprise-support initiative aimed at givingacademics practical business training and consultancy support. In fact Equinome was the overallwinner of the 2009 programme.

“When it became apparent that we had a product with good commercial potential I madecontact with the team at NovaUCD. Their support was really important to the company’sdevelopment as they provided the commercialisation know-how and the IP protectionknowledge which I didn’t have. They also gave me the confidence to believe in my idea. This isreally important when you don’t come from a business background. To have a partner of JimBolger’s calibre and experience on one side and NovaUCD on the other was of huge value.”

In business, timing is everything and, on the face of it, 2010 was not a good year for Equinometo start pitching a pioneering product at the Irish bloodstock market. The industry had suffereda major downturn due to the recession and there was a 40% drop in the number of new foalsbeing born.

Equinome’s original plan of finding its feet in the Irish and UK markets before going internationalwas shelved. “We had to change our strategy very quickly and look to Australia, the US andother overseas markets,” Hill says. “This actually proved beneficial in that we became establishedinternationally much faster than we had intended. As a result, a large proportion of ourcustomers are outside Ireland.”

By the time the Equinome Speed Gene Test was launched, Hill’s team had already begun workon other applications and, in 2011, a second product, the Equinome Elite Performance Test, wasunveiled. This identifies horses with the greatest genetic potential for racecourse success.

Equinome now employs six people in Ireland and has a permanent office in Melbourne, Australia.All of the testing is carried out at UCD with samples flown in daily from around the world.

“We have broken new ground but we won’t be sitting back,” Hill says. “It is our intention tocontinue developing new products and we will be adding another test to our portfolio in thenear future. There is also ongoing work we can do to refine our testing as new pieces oftechnology become available. For now the focus is on the Thoroughbred industry but we maylook at new areas. We are only going three years and did meet a certain level of conservatismearly on. But that has changed. We are talked about in the racing media and people know whowe are.”

While Hill acknowledges that teaching full-time, carrying out research and being involved withEquinome is demanding, she believes that both her company and UCD benefit from her closeassociation with academia and industry. “My research has been critical to the development ofthe company as has access to the body of knowledge that resides in UCD. In return UCDderives income from the licence agreement, there are job opportunities for UCD graduateswith us and the University has strong links with a company at the leading-edge in its field,” shesays.

“I didn’t start out with the expectation of building a successful global business but in fact that is what has been achieved.”

Case StudyKeeping Things Cool in Space

In simple terms, Enbio has developed a ‘sunscreen’ that protects satellitestravelling through space. All going toplan, the company’s technology will beused on board the Solar Orbitersatellite mission to the Sun in 2017.

Dr Denis Dowling and John O’Donoghue

In December 2012, Irish surface technology company Enbio got the breakthrough every start-up dreams of - it landed a substantial contract with the European Space Agency. This broughtinternational peer recognition and positioned the company as a serious player in the spacearena.

In simple terms, Enbio has developed a ‘sunscreen’ that protects satellites travelling throughspace. All going to plan, the company’s technology will be used on board the Solar Orbitersatellite mission to the Sun in 2017.

At the core of the company’s success is CoBlast a patented platform technology developed bycompany founder, John O’Donoghue. “Our technology offers unique surface solutions tochallenges across multiple sectors including aerospace, energy, automotive and medical devices,”he says.

“CoBlast is the grit blasting of a mixed media stream of particles to the surface of a metal inorder to strip off and replace the naturally occurring oxide layer. All modern lightweight metalshave this layer and it makes it difficult to join anything to those surfaces. We have found a waypast that natural barrier and what is underneath is highly reactive. If you can put somethingonto that surface before the oxide layer naturally grows back – which happens in a fraction ofa second – it will bind strongly to the metal, if it has an affinity for it.”

In the case of the Solar Orbiter mission, the CoBlast technology is being used to produce “black”surfaces that combine extreme thermal and ultra-violet radiation stability, robustness, andelectrical conductivity. Together they provide satellites and their payloads with better protectionfrom extreme solar radiation than is currently available.

Enbio, a UCD spin-in company, has been based at NovaUCD since 2011 when the companyrelocated from Cork. “Being based at NovaUCD, in particular, and UCD, in general, has madethis new phase of Enbio sing,” says John O’Donoghue.

“It’s a stimulating environment to work in and a rich environment in which to recruit. There isalso the interaction with the wider University, which is invaluable. The team at NovaUCD hasalso facilitated everything we needed to do to get our manufacturing plant up and running.”

One of Enbio’s key collaborators at UCD is Dr Denis Dowling, Director of the UCD SurfaceEngineering Research Group and winner of the NovaUCD 2012 Innovation Award. Dowling’sextensive experience in this field has led to the successful commercialisation and licensing of anumber of the technologies he has developed. These technologies have subsequently been

applied in areas as diverse as food science and the biocompatibility of implanted medical devices.Since 2003, Dowling has submitted 14 invention disclosures to UCD’s technology transfer teamat NovaUCD.

“NovaUCD provides a framework that allows my research to move to the next stage,” Dowlingsays. “They help assess the commercial potential of an idea and if it has value they will lookafter IP and patenting issues as well as licensing the technology to industry.”

Dowling’s connection with Enbio started out through Enterprise Ireland’s Innovation PartnershipProgramme where UCD’s role was to obtain a fundamental understanding of the technologyEnbio wanted to develop. “From the University’s perspective the interaction was highly beneficialas we had the opportunity to work on a challenging new technology. From the company’s pointof view our involvement gave it access to our knowledge base and to joint publications it wasthen able to use when pitching for financial support to develop the company,” Dowling says.

Enbio’s initial focus was the medical devices sector, but when this market proved over-complicated for a start-up to penetrate, it began looking at alternative industries. “I helped themwrite their first European Space Agency proposal which was successful and they did all therunning from there,” Dowling says.

“Being located at NovaUCD is ideal for a company like Enbio as it provides a framework and afacility that allows entrepreneurs to develop as part of a community. If you’re working on astart-up on your own and you have a bad day it can be very negative.

“At NovaUCD entrepreneurs can bounce ideas and get access to the people they need throughnetworking with like-minded individuals. This sort of collegial engagement is very valuable interms of helping a company to get going,” Dowling adds.

“If you were to ask me what’s the essence of being here at NovaUCD, I’d have to say it’s thecalibre of the people. It’s just a fantastic place to be,” John O’Donoghue says.

“Being based at NovaUCD, in particular, and UCD, in general, has made this new phase of Enbio sing.”

Office of the Vice-President for Innovation

Professor Peter Clinch is UCD’s Vice-President for Innovation and he leads the Office of the Vice-President for Innovation which is based at NovaUCD.The members of the team and their contact details are given below.

Name Position Tel: +353 (0)1 Email:

Professor Peter Clinch Vice-President for Innovation 716 3737 [emailprotected]

Jackie Boyd-Lyons PA to the Vice-President 716 3710 [emailprotected]

Brendan Cremen Director, Enterprise & Commercialisation 716 3718 [emailprotected]

Dr Ciaran O'Beirne Manager, Technology Transfer 716 3713 [emailprotected]

Dr Stacey Kelly Case Manager, Technology Transfer 716 3705 [emailprotected]

Dr François Pichot Case Manager, Technology Transfer 716 3725 [emailprotected]

Dr Karl Quinn Case Manager, Technology Transfer 716 3728 [emailprotected]

Dr Ena Walsh Case Manager, Technology Transfer 716 3706 [emailprotected]

Leonora Doyle Legal Counsel 716 3722 [emailprotected]

Dr Cody Mayoh Project Manager, Enterprise Development 716 3707 [emailprotected]

John Wrigley Administrative Assistant, Technology Transfer 716 3721 [emailprotected]

Helen Mc Grath Operations Manager 716 3711 [emailprotected]

Thomas Hamill Facilities Manager 716 3717 [emailprotected]

Karina King Business Support Executive 716 3719 [emailprotected]

Caroline Gill Innovation Education Manager 716 3715 [emailprotected]

Dr Ciara Leonard Programme Manager, Innovation 716 3714 [emailprotected]

Micéal Whelan Communications Manager 716 3712 [emailprotected]

NovaUCD Reception: The NovaUCD reception can be contacted via t: +353 (0)1 716 3700 or e: [emailprotected]

Contact Details:Office for the Vice-President for InnovationNovaUCDBellield Innovation ParkUniversity College DublinBelfield, Dublin 4, Ireland.t: +353 (0)1 716 3737e: [emailprotected]: www.ucd.ie/innovation

Social Media:Twitter: @UCDinnovation and @NovaUCDFacebook: www.facebook.com/ucdinnovationYouTube: www.youtube.com/ucdinnovationLinkedIn: UCD Innovation and NovaUCD Groups

Updates:If you would like to receive regular updates on news and events of interest please subscribe via www.ucd.ie/innovation/subscribeforupdates

FOST

ERS

AVEN

ROEBUCK ROAD

CLONSKEAGH ROAD

< DUBLIN N11 WEXFORD>

RoebuckCastle

UCD ScienceCentre

N11 ENTRANCE

OWENSTOWN ENTRANCE

RICHVIEW ENTRANCE

CLONSKEAGH ENTRANCE

GREENFIELD ENTRANCE

NovaUCD ENTRANCE

NovaUCD

NovaUCD Location and Directions

The vehicular entrance to NovaUCD is located on Fosters Avenue, approximately 200m from the Stillorgan dual carriageway (N11). The road from this gate leads directly towards NovaUCD. Car parking for visitors is on the right hand side of the road, before reaching NovaUCD.Visitors may also park in one of the University car parks and approach NovaUCD on foot.

For further information contact:Micéal WhelanCommunications ManagerOffice of the Vice-President for Innovation NovaUCDBelfield Innovation ParkUniversity College DublinBelfield, Dublin 4, Ireland.t: +353 (0)1 716 3712e: [emailprotected]

The University Industry Centre (UIC), designed by Ronnie Tallon of Scott Tallon WalkerArchitects, was officially opened on 20 May 1985 by Dr Garret FitzGerald TD, who was AnTaoiseach at the time. The Centre was established as a focal point for University-industry co-operation on the UCD campus.

The Centre was an initiative of the UCD Engineering Graduates Association, which wasestablished in 1982 by Dr John Kelly, Dean of Engineering and Architecture, and its firstchairman, Dr Tom Hardiman. The Engineering Graduates Association believed that the futureof Irish industry could be greatly assisted by closer co-operation between industry and UCD.

Their intention was that the UIC would encourage such interaction by providing a location fortechnical meetings, continuing professional education courses, industrial exhibitions andseminars. The development of the UIC marked the implementation of a new policy in UCDtowards greater University-industry co-operation.

The Engineering Graduates Association established the University Industry Educational Trust toraise funds to finance the construction of the UIC. Under the direction and with the supportof Dr John Kelly, Dr Tom Hardiman and Dr Paddy Galvin, the Trust raised £1 million from some450 individuals and companies. Most of the money came from Irish industry, but also fromengineering academic staff and graduates.

Dr Tom Hardiman was appointed chairman of the board of the UIC, which comprised seniorrepresentatives of industry and the University. Dr Hugh Quigley, who was the Centre’s firstdirector, initiated a range of programmes, particularly in Continuing Professional Education(CPE).

In 1988 Dr Pat Frain was appointed Director and the University Industry Programme (UIP) wasestablished to develop innovation, technology transfer, CPE and other forms of co-operationbetween the University and the industrial and business community in Ireland and overseas.

The Campus Innovation Centre (CIC) was established at Roebuck Castle in 1989 with thesupport of the IDA. The CIC consisted of twelve incubator units in an environment thatfacilitated the start-up and development of knowledge-based enterprises.

Throughout the 1990s the UIP supported the development of a range of successful multidisci-plinary courses at the UIC, new ventures at the CIC and a number of patents and othercommercial opportunities.

In the late 1990s the scarcity of incubation space and other facilities to support the activities ofthe UIP became an increasing constraint to commercialisation, enterprise development andindustry co-operation at UCD.

In 2003 NovaUCD, an €11 million Centre for New Ventures and Entrepreneurs, was openedat Merville House with the support of a unique public-private partnership comprising UCD andAIB Bank, Arthur Cox, Deloitte, Enterprise Ireland, Ericsson, Goodbody Stockbrokers andXilinx.

Appendix 1: From University Industry Centre to NovaUCD

Agricultural Magnetics

AIB Seed Capital Fund

Aonta Technologies

APC

Aquens

Auranta

Belfield Technologies

Berand Neuropharmacology

bioMerieux

Bioplastech

Biosensia

Cernam

CityHook

Connectors Marketplace

Credit Expo Research

Crescent Diagnostics

Dalton Kingswell

DOCOsoft

EgoNav

Enbio

Enzolve Technologies

Equilume

Equinome

HeyStaks

HiberGene Diagnostics

IncaPlex

Innovios

Ionic Business Systems

Kinesis Healthcare Technologies

Life Scientific

MuteButton

New Lambda Technologies

OncoMark

Orion Veterinary

Q-Validus

RendezVu

ServiceFrame

SmartBuilder Software

Socowave

Stair

Synference

Talentevo

Tethras

Voucher Pages

Vu2Vu

Wattics

Appendix 2: NovaUCD Client Companies

Garrett Hussey and Paul Groarke, Co-founders, RendezVu,winners of the 2009, David Manley Emerging Entrepreneur Award

Dr Barbara Murphy, Founder, Equilume, winner EnterpriseIreland 2012 ‘One to Watch’ Award

Members of the Wattics team, winners of the 2012 Best EmergingCompany Award, InterTradeIreland All-Island Seedcorn BusinessCompetition

Dr Ross O’Neill, Founder, MuteButton

NovaUCD's current client companies include:

Appendix 3: NovaUCD Graduate Companies

Advanced Diagnostics Laboratory

AER Sustainable Energy

Alltracel Technologies

Aonta Technologies

AnaTech Silicon

BiancaMed

(now ResMed Sensor Technologies)

Biosystems Engineering

Broadcast Learning

Carbon Decisions

Careergro

Celtic Catalyst

ChangingWorlds (now part of Amdocs)

Cornerstone Knowledge International

Duolog Technologies

Embark Technologies

EnvEcon

Eventznet

Evolution

gsmExchange.com

HomeInstead Senior Care

Homewise.ie

Intelligent Health Systems

Lightwave Technologies

Locumotion

Java Clinical Research

Logentries

LogScreen

Management Briefs

Maritime Management

Restored Hearing

Sportora

VideoCrisp

Visible Thread

Visor

Companies which have graduated from NovaUCD include:

Abhinav Chugh, Founder, VideoCrisp

Ray Bulger, Co-founder, Duolog Technologies Rhona Togher, Co-founder, Restored Hearing

Tony Connolly, Founder, Visor

2012: PurOrigin, Finbarr Maguire and David Ronan, Masters of Engineering students, UCD School of Mechanical and Materials Engineering

2011: APC, Professor Brian Glennon and Dr Mark Barrett, UCD School of Chemical and Bioprocess Engineering

2010: Logentries (JLizard), Dr Trevor Parsons and Dr Viliam Holub, UCD School of Computer Science and Informatics

2009: Equinome, Dr Emmeline Hill, UCD School of Agriculture and Food Science

2008: RendezVu (ASimil8), Paul Groarke and Garrett Hussey, a UCD spin-in company

2007: EnvEcon (AP EnvEcon), Professor Peter Clinch and Dr Andrew Kelly, UCD School of Geography, Planning and Environmental Policy

2006: FitFone, Dr Conor O’Brien, Royal College of Surgeons in Ireland

2005: Vocal Health Screen, Rosalyn Moran, PhD student, UCD School of Electrical, Electronic and Communications Engineering

2004: Nanosense, Dr Margaret Brennan, School of Physics, Trinity College Dublin

Note: In the early years of the CCDP, projects from other third-level institutions in Dublin participated on this programme.

Appendix 4: Winners of the NovaUCD Campus CompanyDevelopment Programme Award (2004-2012)

Dr Trevor Parsons and Dr Viliam Holub, Co-founders, Logentries

Professor Brian Glennon and Dr Mark Barrett, Co-founders, APC

2012: Dr Denis Dowling, UCD School of Chemical and Bioprocess Engineering and UCD School of Mechanical and Materials Science

2011: Professor William Gallagher, UCD School of Biomolecular and Biomedical Science

2010: The Fault Analysis Group, UCD School of Geological Sciences

2009: Nicola Mitchell, founder, Life Scientific, a UCD spin-in company

2008: Celtic Catalysts, a UCD spin-out company

2007: Professor Ciaran Regan, UCD School of Biomolecular and Biomedical Science

2006: Professor Conor Heneghan, UCD School of Electrical, Electronic and Communications Engineering

2005: Professor Barry Smyth, UCD School of Computer Science and Informatics

2004: Professor Mark Rogers, UCD School of Biology and Environmental Science

Appendix 5: Winners of the NovaUCD Innovation Award (2004-2012)

Dr Tom Manzocchi, Dr Conrad Childs and Professor John Walsh,joint Directors of the Fault Analysis Group

Nicola Mitchell, Founder, Life ScientificProfessor William Gallagher and his daughter Kate

Appendix 6: Listing of Inventions Disclosed by UCD Researchers (2004-2013)

Lead Inventor UCD School of Title of Invention Disclosure

Adams, John Electrical, Electronic and Mechanical Engineering Co-Apt ( A medical device for heart valves and leaflets)Albrecht, Martin Chemistry and Chemical Biology Process for fabricating siloxanes and siliconesAllan, Bernard Biomolecular and Biomedical Science Skeletal cell lineAl-Rubeai, Mohamed Chemical and Bioprocess Engineering Disposable RotaBioreactorAl-Rubeai, Mohamed Chemical and Bioprocess Engineering Biomarker for mammalian cell stress in BioreactorsAl-Rubeai, Mohamed Chemical and Bioprocess Engineering Aseptic Sampling Valve Assembly (ASVA)Al-Rubeai, Mohamed Chemical and Bioprocess Engineering An automated straining and flow cytometry process for suspension mammalian cells in culture for the monitoring and analysis of apoptosisArchambault, Daniel Computer Science and Informatics Dynamic Multilevel Tag CloudsBackert, Stefan Biomolecular and Biomedical Science A small fibronectin-mimicking protein from bacteriaBalado, Felix Computer Science and Informatics BioCodeBaugh, John Medicine and Medical Science Leucine-rich alpha-2-glycoprotein is a novel biomarker of ventricular dysfunction and heart failureBelton, Orina Biomolecular and Biomedical Science Nitrosylated Conjugated Linoleic Acid [NCLA]Bertolotto, Michela Computer Science and Informatics Generating Personalised MapsBirtwistle, Marc Biomolecular and Biomedical Science Rapid multiplexed FRET biosensor cloning systemBlanco, Alfonso Biomolecular and Biomedical Science Flow Cytometer SimulatorBleakley, Chris Computer Science and Informatics Method for Predicting the Dynamic Power Consumption of ProcessorsBleakley, Chris Computer Science and Informatics Low Complexity H.264 Video Encoding AlgorithmBleakley, Chris Computer Science and Informatics Enhanced IEEE 802.15.4 to reduce power consumption and latencyBleakley, Chris Computer Science and Informatics Privacy aware location estimation by timing acquisitionBleakley, Chris Computer Science and Informatics Reference free location estimation by timing acquisitionBleakley, Chris Computer Science and Informatics Phase-difference ambiguity resolution for a single frequency signalBleakley, Chris Computer Science and Informatics iBellBleakley, Chris Computer Science and Informatics Method for collision free multi-hop IEEE 802.15.4 networksBleakley, Chris Computer Science and Informatics Motion capture system and method for exercise monitoring in gym (RepSonic)Bleakley, Chris Computer Science and Informatics High accuracy digital ultrasonic range estimationBleakley, Chris Computer Science and Informatics 1-Doppler-tolerant ultrasonic FHSS signal design and receiver algorithm for 3D motion trackingBleakley, Chris Computer Science and Informatics 2-Motion capture system and method for exercise monitoring in gym (RepSonic)Bleakley, Chris Computer Science and Informatics 3-Ultrasonic motion tracking system with low cost Mobile DeviceBrayden, David Veterinary Medicine Anti-inflammatory effects of polymeric conjugatesBrayden, David Veterinary Medicine Polymer-conjugated salmon calcitonin for the treatment of inflammatory conditionsBrayden, David Veterinary Medicine Hyaluronic acid-conjugated salmon calcitonin for the treatment of inflammatory conditions including osteoarthritis, rheumatoid arthritis

Lead Inventor UCD School of Title of Invention DisclosureBrayden, David Veterinary Medicine Use of CriticalSorb-TM as an oral absorption enhancer in intestinal tissueBrayden, David Veterinary Medicine Discovery of a novel epithelial permeation enhancer with potential to orally deliver poorly permeable moleculesBrazil, Tom Electrical, Electronic and Communications Engineering Discrete-Time representation of systemsBrazil, Tom Electrical, Electronic and Communications Engineering PAPR Reduction Technique of OFDM SignalsBrennan, Lorraine Agriculture and Food Science Markers of Oocyte quality that play a role in fertility treatmentBrowne, David Mechanical and Materials Engineering Nano-injection moulding using multiscale metallic glass (amorphous metal) toolsBustamente, Miguel Mathematical Sciences Parallel light beam concentratorByrne, Gerry Mechanical and Materials Engineering Controlled Compliance Tool For GrindingByrne, Gerry Mechanical and Materials Engineering Integrated Drilling, Chamfering and Deburring ToolByrne, Gerry Mechanical and Materials Engineering Tool with dual mode local control (DMLC) for the rotation grinding processByrne, Gerry Mechanical and Materials Engineering Magento-Rheological Elastomer Formulation and control system for active control of the Compliance and Dynamic StiffnessByrne, Gerry Mechanical and Materials Engineering Tool-holder for Improved Cutting Tool Performance in Interrupted MachiningByrne, Gerry Mechanical and Materials Engineering Continuous In-Process Generation of Tool Coatings in MachiningByrne, Paula Biomolecular and Biomedical Science FRET analysis in living cellsCagney, Gerard Biomolecular and Biomedical Science Method for identifying newly translated proteinsCahill, Dolores Medicine and Medical Science Biomarkers of Ovarian diseaseCahill, Peter Computer Science and Informatics Using same language machine translation to create alternative target sequences for text-to-speech synthesisCallanan, Sean Veterinary Medicine Factors influencing lymphotropic viral entry into the central nervous systemCarr, Hamish Computer Science and Informatics Robust Building Outline ExtractionCarr, Hamish Computer Science and Informatics Autiomated transformation of voxelized data into computational meshingCarrington, Stephen Veterinary Medicine Mucoadhesive polymersCarrington, Stephen Veterinary Medicine Mucus degradation therapy for pulmonary useCarrington, Stephen Veterinary Medicine Glycan structure in secreted mucins from the ocular surface of man, rabbit and dogCarrington, Stephen Veterinary Medicine Galactose dependent interactions in the regulation of the characteristics of mucus-gelsCarrington, Stephen Veterinary Medicine Mucin Glycans as therapeutics for Campylobacter infectionCarrington, Stephen Veterinary Medicine Role of mucin sialyation in transcervical sperm migrationCarrington, Stephen Veterinary Medicine Modified carbohydrate derivatives as novel reducing agents for the treatment of pathologic mucus in acute and chronic airway diseaseCarrington, Stephen Veterinary Medicine Carbohydrate-based inhibitors of intelectin as a novel mucolytic and anti-inflammatory strategy for airway diseasesCarrington, Stephen Veterinary Medicine Glycosylation of blood proteins as a prognostic biomarkerCasey, Eoin Chemical and Bioprocess Engineering An antimicrobial potentiator for biofilm associated infectionsCasey, Eoin Chemical and Bioprocess Engineering A process for cleaning a membrane supported biofilm reactorCasey, Eoin Chemical and Bioprocess Engineering Corrugated tubing for the growth of biofilm (Oxymem)Caulfield, Brian Public Health, Physiotherapy and Population Science A Garment for Monitoring PostureCaulfield, Brian Public Health, Physiotherapy and Population Science Method and apparatus for stimulating pelvic floor musclesCaulfield, Brian Public Health, Physiotherapy and Population Science Method and apparatus for stimulating lower back and core musclesCaulfield, Brian Public Health, Physiotherapy and Population Science Rehabilitation Design GamesCaulfield, Brian Public Health, Physiotherapy and Population Science Novel disposable goniometer for measurement of relative angular motion of body segments

Lead Inventor UCD School of Title of Invention DisclosureCaulfield, Brian Public Health, Physiotherapy and Population Science Aerobic exercise variation 27Clyne, Marguerite Medicine and Medical Science The interaction of trefoil peptides with microbial moleculesClyne, Marguerite Medicine and Medical Science Multivalent oligosaccharidesCoburn, Adam Chemistry and Chemical Biology Siphoning waste solvent transfer systemCollier, Rem Computer Science and Informatics A Method of Segmentation for Ranked ListsConway, Rory Physics NodecryptCoyle, Lorcan Computer Science and Informatics 1 - Realtime Analytics at ScaleCoyle, Lorcan Computer Science and Informatics 2 - Fraudulent patterns of interestCoyle, Lorcan Computer Science and Informatics 3 - Social network analytics data representationCoyle, Lorcan Computer Science and Informatics 4 - Integration tools for EgoNavCummins, Enda Biosystems Engineering Antimicrobial surfaces via block copolymer template nanodotsCummins, Fred Computer Science and Informatics Spell checkerCunningham, Padraig Computer Science and Informatics Interpretable toolkit for document clusteringCurran, Kathleen Medicine and Medical Science PreTRACTCurran, Paul Electrical, Electronic and Communications Engineering Flow Control RouterCurran, Tom Biosystems Engineering Water flow recording systemCurran, Tom Biosystems Engineering Carotene combined bleaching (CCB) test kitDalton, Damian Computer Science and Informatics Universal Time Mechanism for Mixed-Level Timing SimulationDalton, Damian Computer Science and Informatics A System Level Power Evaluation MethodDarcy, Rafe Chemistry and Chemical Biology Polypolar Macrocyclic Oligosaccharides and their analogues which fotm molecular layersDarcy, Rafe Chemistry and Chemical Biology Process for selective modification of cyclodextrinDawson, Kenneth Chemistry and Chemical Biology Nanoparticle-based protein harvesting from complex mixturesDawson, Kenneth Chemistry and Chemical Biology Nanoparticle-based visualisation of cell-traffickingDawson, Kenneth Chemistry and Chemical Biology A new combinatorial approach to nanoparticle-based scaffoldsDawson, Kenneth Chemistry and Chemical Biology HCA platform for nanosafety assessmentDawson, Kenneth Chemistry and Chemical Biology Synthetic minimal biological fluids for safety assessment of nanomaterialsDobson, Simon Computer Science and Informatics Nirvana software tool for programming languagesDobson, Simon Computer Science and Informatics Glow TagsDocherty, Jim Medicine and Medical Science Treatment to prevent adhesion formation following surgeryDonnelly, Seamas Medicine and Medical Science MIF inhibitorDonnelly, Seamas Medicine and Medical Science Generic encrypted electronic diary of when an inhaler was usedDonnelly, Seamas Medicine and Medical Science TLR3 mutationDonnelly, Seamas Medicine and Medical Science Novel small molecular weight anti-inflammatory inhibitos in diseaseDonnelly, Seamas Medicine and Medical Science Event recordal device for medicinal dispensersDonnelly, Seamas Medicine and Medical Science Idiopathic Pulmonary FibrosisDoohan, Fiona Biological and Environmental Science A novel eukaryotic gene that confers stress tolerance to plants and yeastDoohan, Fiona Biological and Environmental Science Biological control agents

Lead Inventor UCD School of Title of Invention DisclosureDoohan, Fiona Biological and Environmental Science Novel use of ChitosanDoohan, Fiona Biological and Environmental Science Novel Bacterial StrainsDoohan, Fiona Biological and Environmental Science Novel method for plant transformation using Ensifer bacteriaDoohan, Fiona Biological and Environmental Science Fungal glucosamine production as a byproduct of bioethanol production with the strains of the fungas Fusarium OxysporumDoran, Peter Biomolecular and Biomedical Science EBV induction of pulmonary fibrosisDoran, Peter Biomolecular and Biomedical Science Net1 mediated tumour cell invasionDowling, Denis Mechanical and Materials Engineering Acrylic Acid nano-layer for recyclable PET packagingDowling, Denis Mechanical and Materials Engineering Microwave plasma sintering of metal powders [Nanogrind]Dowling, Denis Mechanical and Materials Engineering Use of atmospheric plasma treatments to enhance thermosealing bond strengthDowling, Denis Mechanical and Materials Engineering Deposition of drug release coatings using an atmospheric plasma jet sysDowling, Denis Mechanical and Materials Engineering Combination of CoBLAST and microwave proocesses for the energy efficient application of coatingsDowling, Denis Mechanical and Materials Engineering Method for deposition of metal oxide coatings for use in photovoltaic cellsDowling, Denis Mechanical and Materials Engineering Method of depositing functional coatings using microwave plasma sinteringDowling, Denis Mechanical and Materials Engineering Method for the deposition of Citrox coatingsDowling, Denis Mechanical and Materials Engineering Method for the deposition of natural bioactive coatingsDowling, Denis Mechanical and Materials Engineering Microwave plasma technique for the doping of solar cell eledtrodesDowling, Denis Mechanical and Materials Engineering Monitoring of surface damage during cold atmospheric plasma treatment using optical emission spectroscopyDowling, Denis Mechanical and Materials Engineering 1-Application method for silane precursors for the improvement of paint-composite adhesionDowling, Denis Mechanical and Materials Engineering Method of enhancing the surface activity of metal oxides during the fabrication of DSSC cellsDowling, Denis Mechanical and Materials Engineering Microwave plasma technique for the doping of solar cell electrodesElia, Giuliano Biomolecular and Biomedical Science A triple quadrupole mass spectrometer with electron transfer dissociation (ETD) sourceEnglish, Niall Chemical and Bioprocess Engineering Algorithmic improvements for electrostatics in classical molecular simulationsEnglish, Niall Chemical and Bioprocess Engineering Algorithmic improvements for electrostatics in classical molecular simulations mapped onto novel hardware platformsEnglish, Niall Chemical and Bioprocess Engineering Algorithmic improvements for ab initio computational treatment of colorimetryEnglish, Niall Chemical and Bioprocess Engineering Separation of chiral liquids via time-dependent circularly polarised electric fieldsEvans, Alex Agriculture and Food Science FIPB - Fibroblast Growth Factor Intracellular Binding ProteinEvans, Alex Agriculture and Food Science Novel genes as a target for manipulating ovarian follicle developmentFair, Trudee Agriculture and Food Science Biomarkers of bovine oocyte developmental potentialFitzpatrick, David Computer Science and Informatics Method and Software for the Predictive Modelling of Scholiotic Deformity and Implant Design for Curve CorrectionFitzpatrick, David Mechanical and Materials Engineering Wearable Sensing and Control System (Intelligent vest) for Musculoskeletal Monitoring and Correction/TreatmentFitzpatrick, David Mechanical and Materials Engineering Swift Mobility AidFitzpatrick, John Computer Science and Informatics IPTV MonitoringFlanagan, Mark Electrical, Electronic and Communications Engineering An encoding scheme and a decoding scheme using a series of LDPC codes based on finite inversive spacesForde, Niamh Agriculture and Food Science Pregnancy markers based on uterine gene expression associated with early pregnancy statusGallagher, Helen Medicine and Medical Science DevTox AssayGallagher, William Biomolecular and Biomedical Science Multiple markers for melanoma progression regulated by DNA methylationGallagher, William Biomolecular and Biomedical Science Isolation and identification of 3 proteins, cystatin C, PBPP and beta-2-microglbulin, as diagnostic markers for apoptosis and tumour growth

Lead Inventor UCD School of Title of Invention DisclosureGallagher, William Biomolecular and Biomedical Science Novel image analysis algorithms for quantifying expression of nuclear proteins assessed by immunohistochemistryGallagher, William Biomolecular and Biomedical Science Novel image analysis algorithms for quantifying expression of nuclear proteins assessed by immunohistochemistryGallagher, William Biomolecular and Biomedical Science Generation and the use of mice bearing tissue-specific expression of luciferase for advanced bioluminescence-based imaging in transgenic

tumour modelsGallagher, William Biomolecular and Biomedical Science The Cocaine and Amphetamine Regulated Transcript (CART) as a prognostic marker in lymph node-negative breast cancerGallagher, William Biomolecular and Biomedical Science MiR-187: A prognostic marker in Estrogen Receptor positive breast cancer patientsGavin, Kenneth Civil, Structural and Environmental Engineering Hybrid Accelerated Raft-Pile (HARP) foundation solution for the offshore wind energy industryGilchrist, Michael Mechanical and Materials Engineering Functionally graded foams for improving impact performance of safety helmetsGilchrist, Michael Mechanical and Materials Engineering Impact absorption mechanismGilchrist, Michael Mechanical and Materials Engineering A clothes dryerGilheany, Declan Chemistry and Chemical Biology Novel method of preparation of unsymmetrical salen ligands/complexes, via in-situ reduction/oxidationGilheany, Declan Chemistry and Chemical Biology Conversion of phosphines and phosphine oxides to phosphine boranes using either chlorinating or alkylating agents in combination with

sodium borohydrideGladyshev, Pavel Computer Science and Informatics An algorithm (YD Algorithm) for forensic analysis of changed entries between two snapshots of MRU keyGladyshev, Pavel Computer Science and Informatics ShellBag forensicsGladyshev, Pavel Computer Science and Informatics Digital Investigation Process Support and Task Automation Method and ApparatusGlennon, Brian Chemical and Bioprocess Engineering Continuous crysatllization platformGodson, Catherine Medicine and Medical Science Anti-MATA-1, a novel antifibrotic bio therapeuticGreene, Barry Public Health, Physiotherapy and Population Science Detection of neonatal seizuresGreene, Derek Computer Science and Informatics System for tracking the evolution of communities in dynamic social networksGreene, Derek Computer Science and Informatics System for Twitter User List CurationGreene, Derek Computer Science and Informatics System for event detection on TwitterGreene, Derek Computer Science and Informatics Term recommendation system based on co-occurrence in curated user listsGreene, Derek Computer Science and Informatics Facebook advertising campaign setup, analysis and optimisationGreferath, Marcus Mathematical Sciences Low-Power Excitation for Magnetic ResonanceGuiry, Pat Chemistry and Chemical Biology LipoxiodineGuiry, Pat Chemistry and Chemical Biology Anti inflammatory marine compoundGutierrez, Jorge Veterinary Medicine Multiplex diagnostic real time PCR test for ovine abortionsHanlon, Lorraine Physics Gamma Ray OpticsHarden, Theo Languages and Literatures Online tool for computer-aided indirect codes feedback on written compositionsHarrigan, Martin Computer Science and Informatics EgoNav: Exploring networks through egocentric spatializationsHarrigan, Martin Computer Science and Informatics EgoNav: Prototype written in Ruby and Java SEHarrigan, Martin Computer Science and Informatics EgoNav: StormbytesHeneghan, Conor Electrical, Electronic and Communications Engineering Methods and Apparatus for Monitoring SleepHeneghan, Conor Electrical, Electronic and Communications Engineering OFDM signal saturation for either increased transmitted signal power, or reduced energy consumption of the transmitterHeneghan, Conor Electrical, Electronic and Communications Engineering Clipped OFDM signal scaling in the receiver for optimum detection or reduced SER convergence levelHill, Emmeline Agriculture and Food Science mRNA and equine performance

Lead Inventor UCD School of Title of Invention DisclosureHill, Emmeline Agriculture and Food Science SNPs and equine racingHill, Emmeline Agriculture and Food Science Thoroughbred Athletic PerformanceHill, Emmeline Agriculture and Food Science SNP in HIF1AHill, Emmeline Agriculture and Food Science An autosomal DNA-based test for male fertility in horsesHill, Emmeline Agriculture and Food Science A genetic test for bull fertilityHill, Emmeline Agriculture and Food Science MSTN polypmorphism - MSTN insertion/discovery - thoroughbredHurley, Neil Computer Science and Informatics Spatial Sampling Grid RecoveryHurley, Neil Computer Science and Informatics Diversity OptimizerHurley, Neil Computer Science and Informatics MOSES: Detecting highly overlapping communities with Model-based Overlapping Seed ExpansionHussey, Martin Electrical, Electronic and Mechanical Engineering Sharpness indexIvankovic, Alojz Mechanical and Materials Engineering Surrogate lung material for trauma studiesIvankovic, Alojz Mechanical and Materials Engineering Improvement of the flexural strength of superhard materials by heat treatmentJacque, Jean-Marc Medicine and Medical Science Specific killing of lentivirus-infected cells by short bioactive peptides and use thereofJacquier, Jean-Christophe Agriculture and Food Science Dry cross-linked protein as encapsulation matrix for heat sensitive bioactivesJenner, Florien Veterinary Medicine Induced articular connective tissue progenitor cellsJenner, Florien Veterinary Medicine Induced articular chondrocyte progenitor cellsJurdak, Raja Computer Science and Informatics Scalable and Unified Management and Control of Large Scale Sensor NetworksKavanagh, David Biomolecular and Biomedical Science Scrazzl.comKelly, Daniel Public Health, Physiotherapy and Population Science Algorithm to automatically detect tackles in rugbyKennedy, Breandan Biomolecular and Biomedical Science Novel Anti-angiogenic drugsKennedy, Breandan Biomolecular and Biomedical Science 1-Novel anti-angiogenic drug (11B)Khan, Mojibur Biological and Environmental Science Fusarium oxysporum strain 11 C-mediated 4-ethylguaiacol production from wheat straw and branKilinc, Devrim Chemistry and Chemical Biology A cell-benign microfluidic culture platform to study cell migration and signalling in response to complex concentration gradientsKinsella, Therese Biomolecular and Biomedical Science Regulation of the human TXA2 gene by Sp1, Egr1, NF-E2, GATA-1 and Ets-1 in MegakaryocytesKinsella, Therese Biomolecular and Biomedical Science WT1 acts as a key transcriptional repressor of the human TXA2 receptor gene in megakaryocytesKinsella, Therese Biomolecular and Biomedical Science Induction of human TXA2 expression during megakaryocytic differentiationKinsella, Therese Biomolecular and Biomedical Science Regulation of the Human Prostacyclin Receptor by Intestinal and Kidney-enriched PDZ protein (IKEPP)Kinsella, Therese Biomolecular and Biomedical Science Regulation of the InaD-like (Drosophila) Protein (INADL).Kinsella, Therese Biomolecular and Biomedical Science Regulation of the Multi-PDZ domain protein 1 (MUPP1).Kinsella, Therese Biomolecular and Biomedical Science Regulation of the Human Prostacyclin Receptor by PDZ Domain Containing Protein 1 (PDZK1).Kinsella, Therese Biomolecular and Biomedical Science Interaction between the Human Thromboxane A 2 Receptor and Anglo-Associated Migratory Cell ProteinKinsella, Therese Biomolecular and Biomedical Science Identification of novel bio-active peptide sequences within the human prostacyclin receptor and Rab11.Kinsella, Therese Biomolecular and Biomedical Science Development of novel antagonists to selectively target the TP-alpha and TP-beta isoforms of the human thromboxane A2 receptorKinsella, Therese Biomolecular and Biomedical Science A new small molecule for use as an anti-influenza, general anti-viral and bio-defence drugKinsella, Therese Biomolecular and Biomedical Science Discovery of the efficacy of a new anti-cancer drug in a preclinical mouse model of experimental cancer mestastasisKinsella, Therese Biomolecular and Biomedical Science A new small molecule for use as an anti-restenosis and anti-thrombotic drug coating on stents and balloons for use in percutaneous

cardiovascular interventions

Lead Inventor UCD School of Title of Invention DisclosureKolch, Walter Biomolecular and Biomedical Science MST2-RAF1 protein interaction inhibitorsLaefer, Debra Civil, Structural and Environmental Engineering Insulator plate to minimize transport-induced vibration impacts on existing buildingsLaefer, Debra Civil, Structural and Environmental Engineering Enablement of three-dimensional hosting, indexing, analysing and querying structures for spatial systemsLaefer, Debra Civil, Structural and Environmental Engineering Automated Building Boundary and Feature DetectionLaefer, Debra Civil, Structural and Environmental Engineering Automated boundary and aperture detection in pixelized datasets through voxel characterisation and clusteringLee, Gil Chemistry and Chemical Biology F-NLM: Non-linear Magnetophoretic Transport under Continuous Flow for Separation of Magnetic ParticlesLee, Gil Chemistry and Chemical Biology Bacteriophages as molecular recognition system for biodetection, affinity separation and purification processesLee, Gil Chemistry and Chemical Biology Peptide, multimeric peptide and polypeptides probes against the soybean-derived Bowman Birk InhibitorLee, Gil Chemistry and Chemical Biology Hollow / porous Superparamagnetic MicrospheresLee, Gil Chemistry and Chemical Biology Controlled aggregation of nanorods for detection of analytesLee, Gil Chemistry and Chemical Biology Superparamagnetic microparticles with dimpled and crumpled morphologiesLee, Gil Chemistry and Chemical Biology Couette type shear device with separate inlets for continuous and dispersed phasesLee, Gil Chemistry and Chemical Biology Peptide probes for HSV detectionLonergan, Pat Agriculture and Food Science Genes as targets for manipulating embryo development in cattleLonergan, Pat Agriculture and Food Science Six endometrial genes as markers of or as targets to manipulate embryo development in cattleLu, Jian Ping Medicine and Medical Science Automated A & C Platform TechnologyLyng, James Agriculture and Food Science Ohmic heating applicator for semi-continuous ohmic heating of meat and meat productsLyng, James Agriculture and Food Science Ohmic heating deviceMacHugh, David Agriculture and Food Science A genetic test for growth and feed efficiency in bullsMacHugh, David Agriculture and Food Science Circulating microRNAs as diagnostic biomarkers for bovine tuberculosisMallon, Patrick Medicine and Medical Science Monocyte Intracellular Cholesterol AssayMarques-Silva, Jorge Computer Science and Informatics New Model for SAT-based ATPGMartin, Finian Biomolecular and Biomedical Science IHG-1McCann, Amanda Medicine and Medical Science MAD2 (Mitotic Arrest/Assembly Deficiency) protein 2 as a predictor of chemosresponse and patient outcomeMcCarthy, Kevin Computer Science and Informatics SimpleFlow: Gesture prediction, abbreviation and autocompletionMcCarthy, Kevin Computer Science and Informatics Aficinado - 1McCormack, Tom Physics Soft X-Ray microscopeMcCormick, Aiden Medicine and Medical Science Treatment to prevent adhesion formation following surgeryMcDonnell, Susan Chemical and Bioprocess Engineering Cell line as model for invasive breast cancerMcGinty, Lorraine Computer Science and Informatics iCARE - Intelligent Customer Assistance For Recommending EyewearMcGuire, Gary Mathematical Sciences 4 Torsion PointsMcLaughlin, David Biomolecular and Biomedical Science Methods of treating Neurodegenerative diseases by modification of cell types from amniotic fluidMcLaughlin, David Biomolecular and Biomedical Science Cholinergic neurotransmitter phenotype derived from AFCsMcLaughlin, David Biomolecular and Biomedical Science Multineurotransmitter phenotype derived from AFCs for use in High Throughput ScreeningMcLaughlin, David Biomolecular and Biomedical Science Serotonergic neurotransmitter phenotype drived from AFCsMcLaughlin, David Biomolecular and Biomedical Science Skin AFC

Lead Inventor UCD School of Title of Invention DisclosureMcLaughlin, David Biomolecular and Biomedical Science Derviation of mesenchymal stem cells from amniotic fluid - for use in NEURONAL: cell therapyMcMahon, Hilary Biomolecular and Biomedical Science Cyclodextrins for use as anti-prion compoundsMcMahon, Hilary Biomolecular and Biomedical Science Antiprion action of new cyclodestrins analoguesMcMahon, Hilary Biomolecular and Biomedical Science A novel protease for restricting the spread of prion relating diseasesMerino, Alejandro Biomolecular and Biomedical Science Methods for the use of reversible and irreversible affinity reagents to target fusion proteinsMerino, Alejandro Biomolecular and Biomedical Science Applications of ligand-induced interactionsMerino, Alejandro Biomolecular and Biomedical Science Methods for the use of domains or subdomains for immobilisation of fusion proteins [Split-tag]Morgan, Grace Chemistry and Chemical Biology Preparation of nanowires of spin transition complexes in an ordered perpendicular orientation for surface depositionMoynagh, Paul Biomolecular and Biomedical Science Inhibitor of EndotoxinMulcahy, Grace Veterinary Medicine Development of a vaccine against sea lice of salmon using recombinant proteinsMurphy, Barbara Veterinary Medicine Equilume light mask for horsesMurphy, Cormac Biomolecular and Biomedical Science Streptomyces globosus IMD 2703: a novel strain that produces an anti-MRSA antibioticMurphy, Cormac Biomolecular and Biomedical Science Rumbrin derivatives with improved anti-tumour propertiesMurphy, Cormac Biomolecular and Biomedical Science Immobilised fungal biocatalyst for drub metabolite productionMurphy, Keith Biomolecular and Biomedical Science Novel treatment for Multiple Sclerosis with the nootropic agent NefiracetamMurphy, Liam Computer Science and Informatics Association Routing Table for Multi-Homed CommunicationMurphy, Liam Computer Science and Informatics LACAM : Link Adaptation Codec Adaptation MechanismMurphy, Liam Computer Science and Informatics Low Latency roaming support in wireless multi-hop mesh networksMurphy, Liam Computer Science and Informatics Inter-gateway roaming support in wireless multi-hop mesh networksMurphy, Liam Computer Science and Informatics VidAs - Reliable multi-source streamingMurphy, Paul Chemistry and Chemical Biology Novel synthesis of 1-deoxynojirimycin and castanospermine from L-sorboseMurphy, Paul Chemistry and Chemical Biology N-(Alkynylphenoxy)alkyl-1-deoxynojirimycin derivatives as inhibitors of agiogeniesis dependent diseaseMurphy, Paul Chemical and Bioprocess Engineering Design and synthesis of peptidomimetics based on salicyclic acid lactone scaffoldsMurphy, Sean Computer Science and Informatics Bluebook - providing integration of social networks with short range radio technologyMurphy, Sean Computer Science and Informatics Voice over IP audioconference bridgeMurphy, Sean Computer Science and Informatics LocalSocial - social proxiity frameworkMurphy, William Medicine and Medical Science A device to measure the gap between the capillary and venous haemoglobin levels in real timeMurphy, William Medicine and Medical Science A class of drugs to modulate the gap between the capillary and venous/arteriolar haemoglobin levelsNafaa, Abdelhamid Computer Science and Informatics 1 - Advanced stream-control mechanisms for a two-tiered multi-homed networking architectureNafaa, Abdelhamid Computer Science and Informatics 2 - A two-tiered multi-homing archtiecture for seamless mobile data traffic offloadingNafaa, Abdelhamid Computer Science and Informatics 3 - Advanced stream-control mechanisms for a two-tiered multi-homed networking architectureNafaa, Abdelhamid Computer Science and Informatics 4 - Method and apparatus to enable endpoint centric NAT traversal for multi-homed protocolsNafaa, Abdelhamid Computer Science and Informatics 5 - A two-tiered multihoming architecture for seamless mobile data traffic offloading to 3rd party wireless networksNally, Jarlath Veterinary Medicine Diagnostic antigens for Chlamydophila abortusNally, Jarlath Veterinary Medicine Real time PCR detection of pathogenic Leptospira genomesNg, Carl Biological and Environmental Science A polycistronic, inducible system for guard cell specific gene expression in plants

Lead Inventor UCD School of Title of Invention DisclosureNg, Carl Biological and Environmental Science Pollen-specific promoter from ArabidopsisNielsen, Jens Biomolecular and Biomedical Science PEAT_SANielsen, Jens Biomolecular and Biomedical Science PEAT_DataBaseNieuwenhuis, Maarten Agriculture and Food Science PractiSFM: A multi-resource inventory and decision support system for sustainable forest managementNixon, Paddy Computer Science and Informatics Construct – platform for constructing context aware and autonomic systemsNixon, Paddy Computer Science and Informatics Building bridges: a communication device for the elderlyNixon, Paddy Computer Science and Informatics System and method to objectively assess walking and turning during the Timed Up and Go testNixon, Paddy Computer Science and Informatics Handheld GSR Biofeedback deviceO'Brien, Bill Electrical, Electronic and Mechanical Engineering Sparse delay vector calculationO'Connell, David Medicine and Medical Science EF hand affinity tag systemO'Connor, Kevin Biomolecular and Biomedical Science Directed evolution of styrene monooxygenase from Pseudomonas putida CA-3: generaltion of an improved biocatatystO'Connor, Kevin Biomolecular and Biomedical Science Expression of recombinant p-hydroxyphenylacetic acid (PHPA) hydroxylase genes (hpaBC) in Escherchia coli BL21 O'Connor, Kevin Biomolecular and Biomedical Science The conversion of a mixture BTEX compounds by defined mixed cultures to medium chain length polyhydroxyalkanoateO'Connor, Kevin Biomolecular and Biomedical Science Conversion of waste polyethylene terephthalte (PET) to polyhroxyalkanoate (PHA) a biodegradable polymer, via a chemobiotechnological

processO'Connor, Kevin Biomolecular and Biomedical Science 1-Hydroxyalkanoyl-peptide as an anti-cancer agentO'Connor, Kevin Biomolecular and Biomedical Science 2-Hydroxyalkanoyl-peptide as an anti-cancer agent (2012)O'Connor, Kevin Biomolecular and Biomedical Science Conversion of cellulose material to polyhydroxyalkanoateO'Connor, Kevin Biomolecular and Biomedical Science Upcycling of post consumer PE to a biodegradable plasticO'Connor, William Mechanical and Materials Engineering Motion control strategies for flexible mechanical systemsO'Doherty, John Agriculture and Food Science Laminarin and fucoidan compositions to ameliiorate the effects of PCV2 in pigsO'Doherty, John Agriculture and Food Science Supplementing the maternal diet with a combination of laminarin and fucoidan and fish oil will improve gastrointestinal health and

performanceO'Doherty, John Agriculture and Food Science The application of Lactobacillus plantarum in pig diets to alter distal gastrointestinal pig tract compositionO'Farrelly, Cliona Medicine and Medical Science Synthetic antimicrobial peptides with optimised activity against target pathogensO'Farrelly, Cliona Medicine and Medical Science Novel bovine Antimicrobial peptidesO'Hare, Greg Computer Science and Informatics Cluster Aggregation Point Reassignment for Load Balancing in Sensor NetworksO'Hare, Greg Computer Science and Informatics Adaptive Low Power Sleeping Modes of Wireless Nodes in Sensor NetworksO'Mongain, Eon Physics Newly applied technology for an above water spectral reflectometer system for water monitoringO'Mullane, Brian Electrical, Electronic and Mechanical Engineering RAPID: Radio Broadcast Audio Processing for Indexing, Segmentation, Databasing and ArchivingO'Mullane, Brian Electrical, Electronic and Mechanical Engineering Advertisem*nt spotting for quality control and competitor analysisO'Mullane, Brian Electrical, Electronic and Mechanical Engineering Physio Egg TrainerO'Neill, Michael Computer Science and Informatics A technique for detecting and characterizing coverage gaps within a femtocell groupO'Reilly, Fergal Physics High Power EUV Lamp SystemO'Reilly, Fergal Physics Method of Coating a thin Liquid Metal Film onto a Solid SubstrateO'Reilly, Fergal Physics Narrowband X-ray filter for high contrast diagnostic imaging at a lower dose

Lead Inventor UCD School of Title of Invention DisclosureO'Reilly, Fergal Physics Method of removing an oxide layer from a rotating Liquid Metal opticO'Reilly, Fergal Physics Nanoscale spatial resolution, nanosecond time resolution detector for soft x-ray and optical microscopy at various wavelengthsO'Reilly, Fergal Physics Plasma shutterO'Reilly, Fergal Physics Self healing windowO'Reilly, Fergal Physics Nanoparticle drug delivery methodO'Riordan, Dolores Agriculture and Food Science High fibre crispy cheesy snackO'Riordan, Dolores Agriculture and Food Science Cheese snack modificationO'Riordan, Dolores Agriculture and Food Science Production of a functional beverage with anti-inflammatory properties using extracts from medicinal herbsO'Shea, Donal F. Chemistry and Chemical Biology Near Infrared FluorochromesO'Shea, Donal F. Chemistry and Chemical Biology Silicon based reagents as radically improved alternative for general use in all fine chemical manufactureO'Shea, Donal Medicine and Medical Science Use of liraglutide in treatment of psoriasisO'Sullivan, Jacintha Medicine and Medical Science Use of human colonic tumour tissue to test response to chemotherapyO'Sullivan, Conall Business Option Pricing under Explicit Finite Difference Super Time Stepping and Split Diffusion schemesO'Sullivan, Gerard Physics High Power Extreme Ultraviolet Lamp Power SupplyParadisi, Francesca Chemistry and Chemical Biology Method for synthesis of alpha-keto acidsPennington, Steve Biomolecular and Biomedical Science A method comprising a serum biomarker signature for predicting extracapsular extension in prostate cancerPerry, Phillip Computer Science and Informatics A system and method for monitoring stream quality in packet switched networksPhillips, Andrew Chemistry and Chemical Biology Rapid Catalytic Dihydrogen Decoupling using beta-Diketiminato-Ruthenium ComplexesPhillips, Andrew Chemistry and Chemical Biology Silverscudo - Low toxicity Broad Spectrum Silver-Phosphine AntiobioticPhillips, Andrew Chemistry and Chemical Biology Dehydrogenation catalystPollastri, Gianluca Computer Science and Informatics Porter SoftwarePollastri, Gianluca Computer Science and Informatics PaleAleQuigley, Aaron Computer Science and Informatics SenseTiles: a readily-deployable sensor platform for smart buildingsQuigley, Aaron Computer Science and Informatics Meetspace: Perosnalised environmental advertisem*ntsRegan, Ciaran Biomolecular and Biomedical Science MeparfynolRegan, Ciaran Biomolecular and Biomedical Science CaptodiamineRegan, Ciaran Biomolecular and Biomedical Science MidkineRegan, Ciaran Biomolecular and Biomedical Science Schizo TxPRegan, Ciaran Biomolecular and Biomedical Science USAG-BMPRegan, Ciaran Biomolecular and Biomedical Science BACERegan, Ciaran Biomolecular and Biomedical Science Cognition TxPRegan, Ciaran Biomolecular and Biomedical Science InterferonRegan, Ciaran Biomolecular and Biomedical Science NPY Y2Regan, Ciaran Biomolecular and Biomedical Science TransthyretinRegan, Ciaran Biomolecular and Biomedical Science Predictive assay for in vivo detection of cognition-enhancing drugsRegan, Ciaran Biomolecular and Biomedical Science Series of novel compounds with a chemical similarity to (+/-)-n,n-dimethyl-n-(2-{[[4-(n-butylthio) henyl] - (phenyl) methyl] -thio}ethyl) amineRegan, Ciaran Biomolecular and Biomedical Science A series of novel compounds with a chemical similarity to 3-methylpent-1-3-ol (Meparfynol)

Lead Inventor UCD School of Title of Invention DisclosureReilly, Richard Electrical, Electronic and Mechanical Engineering A System For Maintaining Vigilance And AttentionReilly, Richard Electrical, Electronic and Mechanical Engineering A System For Maintaining Vigilance And AttentionReilly, Richard Electrical, Electronic and Mechanical Engineering Remote Assessment of a UserReilly, Richard Electrical, Electronic and Mechanical Engineering Automatic classification of shoeprints for use in forensic science based on image processingReilly, Richard Electrical, Electronic and Mechanical Engineering Combination of ECG and EEG for Detection of Neonatal SeizuresReilly, Richard Electrical, Electronic and Mechanical Engineering Spread spectrum stimulation for rapid estimation of a visual evoked potentialReilly, Richard Electrical, Electronic and Mechanical Engineering Assessment of schizophrenia based on speech analysisReilly, Richard Electrical, Electronic and Mechanical Engineering Remote monitoring device for respiratory measurementsReynaud, Emmanuel Biological and Environmental Science A multi-view imaging deviceRice, James Physics Chemical mapping on the NanoscaleRickard, Scott Electrical, Electronic and Communications Engineering A Method and Apparatus for Blind Source SeparationRickard, Scott Electrical, Electronic and Communications Engineering D-WE: Dual-Window optimized audio EqualizationRickard, Scott Electrical, Electronic and Communications Engineering Historical-Relative Amplitude Turbulence Estimator (H-RATE)Roche, Helen Public Health, Physiotherapy and Population Science Il - 1RA Potential anti-diabetic agentRubagotti, Enrico Information and Library Studies CryptoSpeechRuzzelli, Antonio Computer Science and Informatics REAR: Recognition of Electrical Appliance Activity in Real-timeRuzzelli, Antonio Computer Science and Informatics LoCon: A method for splitting utility bills based on user location and energy consumptionRuzzelli, Antonio Computer Science and Informatics 1 - Equipment activity monitoring via centralised profiling and load processingRuzzelli, Antonio Computer Science and Informatics 2 - Networked Equipment activity monitoring via VLAN auditingRuzzelli, Antonio Computer Science and Informatics 3 - Framework for robust load disaggregationSheridan, John Electrical, Electronic and Communications Engineering LED based Solar Simulator and lighting controlShields, Denis Biomolecular and Biomedical Science OccludinShields, Denis Medicine and Medical Science Searching chemical compound libariesShields, Denis Medicine and Medical Science Prediction of bioactive peptides in milk proteinsShields, Denis Medicine and Medical Science Discovering small molecule inhibitors of protein-protein intereactions through computational dockingShuhaibar, Maher Medicine and Medical Science Easy SealSmolenski, Albert Medicine and Medical Science Use of phosphorylation site specific antibody against phosphorylated serine 7 of Rap1GAP2 protein Smyth, Barry Computer Science and Informatics A Meta Search EngineSmyth, Barry Computer Science and Informatics Collaborative Web Search for Social Networking ServicesSmyth, Barry Computer Science and Informatics HeyStaks: Web Search, SharedSmyth, Barry Computer Science and Informatics Real-time information filter for newsSmyth, Barry Computer Science and Informatics Location-based photographic assistanceSmyth, Barry Computer Science and Informatics Real time feeds for product recommendationSmyth, Barry Computer Science and Informatics Search and discovery engine for real-time web content and hyperlinks,shared via human sharing activitiesSmyth, Barry Computer Science and Informatics Skillpages/Weedle - Innovation Partnership documented know-howSmyth, Barry Computer Science and Informatics Clarity: Profiling of Twitter users for topic-based recommendation

Lead Inventor UCD School of Title of Invention DisclosureSmyth, Barry Computer Science and Informatics Clarity: Reviewer's assistantSmyth, Barry Computer Science and Informatics Analysis of product reviewsStanton, Kenneth Mechanical and Materials Engineering CeraToolStanton, Kenneth Mechanical and Materials Engineering 1 - StellarWHite optical control coating for spacecraftStanton, Kenneth Mechanical and Materials Engineering 2 - Hybrid glass/glass-ceramic (HGGC) material for use in spacecraft coatingsStowe, John Medicine and Medical Science IMage Predictive Artefact Correction Technique (IMPACT)Sullivan, James Chemistry and Chemical Biology The coupling of a CO2 extraction and delivery system to a CO2 reduction catalystSullivan, Matt Biomolecular and Biomedical Science OverwinterTacke, Matthias Chemistry and Chemical Biology Titanocene CTacke, Matthias Chemistry and Chemical Biology Titanocene YTacke, Matthias Chemistry and Chemical Biology Achiral Indole-substituted Metallocene anti-cancer drugsTacke, Matthias Chemistry and Chemical Biology Achiral non-cationic aminobenzyl-substituted Titanocene anti-cancer drugsThampi, Ravi Chemical and Bioprocess Engineering A new design for dye or quantum Dot Sensitised Solar CellThampi, Ravi Chemical and Bioprocess Engineering Method for oxidative removal of organic binder materials and residues from printed layers and sintering of semiconductor compounds Thampi, Ravi Chemical and Bioprocess Engineering Enhancement of thermal stability and recoverable performance of dye sensitized solar cells (DSSC) treated with ultra-thin ZnO coatings Thampi, Ravi Chemical and Bioprocess Engineering Perovskite [LSCO} based electrolyte for dye sensitized solar cellsTimoney, David Electrical, Electronic and Mechanical Engineering Diesel Engine NOX Emission EstimatorTubridy, Niall Medicine and Medical Science Stroke busterVeale, Tony Computer Science and Informatics A Radial Thesaurus based on principles of Semantic Distance and Analogical SimilarityVohnsen, Brian Physics Ultrasmall spot-size scanning laser ophthalmoscope (USLO)Vohnsen, Brian Physics Intraocular lens with spectral correction of the Stiles-Crawford effect for improved chromatic performanceWalsh, Eamonn Business Automated Generation of Accounting ProblemsWard, Shane Biosystems Engineering CyberBar: an integrated anti-tamper food traceability system based on dot matrix branding and cyberneticsWatson, Chris Medicine and Medical Science Methylation inhibitors for the treatment of hypertrophy and fibrosisWorrall, Margaret Biomolecular and Biomedical Science The use of a heparin - serpin combination therapy for inhibition of cancer metastasis.Zerulla, Dominic Physics Novel, Tuneable Molecular Sensor for Biosciences and DiagnosticsZerulla, Dominic Physics Plasmonic enhancement of thin film solar cellsZerulla, Dominic Physics Plasmonic enhanced dye sensitised solar cells via chemical functionalisation of gold nanoparticlesZerulla, Dominic Physics Plasmonics enhanced solar cellsZhu, Anding Electrical, Electronic and Communications Engineering Hardware implementation of digital predistorter for RF power amflifiers based on dynamic truncated Volterra seriesZhu, Anding Electrical, Electronic and Communications Engineering A single envelope modulator-based envelope-tracking structure for multiple-input and multiple-output wireless transmittersZhu, Xiangming Chemistry and Chemical Biology Novel Potent Immunostimulant

NovaUCD’s Impact 2003 -2013

“Great things are not done by impulse, but by a series of small things brought together.”

Vincent van Gogh (1853-90)

NovaUCD is sponsored by AIB Bank, Arthur Cox, Deloitte, Enterprise Ireland, Ericsson, Goodbody, UCD and Xilinx.

CELEBRATING 10 YEARS OF ENTREPRENEURIAL SUCCESS · Professor Peter Clinch, UCD Vice-President for Innovation 2. NovaUCD’s success in the area of technology transfer is equally compelling: - [PDF Document] (2024)

References